Share your contact details to receive free updated sample copy/pages of the recently published edition of Radiotheranostics Market Report 2023.
Key Insights from Radiotheranostics Market Report
"Global Radiotheranostics market size 2022 was XX Million. Radiotheranostics Industry compound annual growth rate (CAGR) will be XX% from 2023 till 2030."
Radiotheranostics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Radiotheranostics Market Report Description
Market Dynamics such as Drivers, Restraints, Opportunities, Trends data
Radiotheranostics Industry Dynamics
- Market Drivers of Radiotheranostics: The key factors which influence the overall sales demand for Radiotheranostics Industry in a positive way. Market drivers help you understand the impact on market growth. With this information you can predict how said market is likely to grow in the coming year.
- Market Restraints of Radiotheranostics: Restraints are the negative factors which hinder the market growth and development in the near future. Some of the restraining factors including strict government regulations, supply chain disruptions, changing consumer preference are affecting the market growth in the near future. For example, the outburst of COVID-19 affected the most of the industries. Restraining factors are important to analyse on account of companies can develop strategies to overcome their negative impact on the growth of the market.
- Market Opportunities of Radiotheranostics: Market opportunities are expected to open up growth window for the new entrants in the market. It helps to understand unmet needs or an untapped potential in the market.
- Market Trends of Radiotheranostics: (This information will be part of the paid report version.)
Radiotheranostics Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Radiotheranostics Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Radiotheranostics Market Segmentation
- 1.5.1 Radiotheranostics Market Regional Fragmentation
- 1.5.1 Radiotheranostics Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Radiotheranostics Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Radiotheranostics Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Radiotheranostics industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Radiotheranostics Market Size 2018 – 2030, (USD Million)
- 3.2 Global Radiotheranostics Value, Absolute & Opportunity Analysis
- 3.3 Global Radiotheranostics Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Radiotheranostics Market Statistics 2022: Snapshot
- 4.1 Radiotheranostics Introduction
- 4.2 Global Radiotheranostics Market Statistics by Regions (2018-2030)
- 4.2.1 North America Radiotheranostics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Radiotheranostics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Radiotheranostics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Radiotheranostics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Radiotheranostics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Radiotheranostics Market Size (2018-2030)
- 4.3.1 Global Radiotheranostics Revenue Status and Outlook (2018-2030)
- 4.4 Global Radiotheranostics Market Price Analysis by Regions (2018-2030)
- 5.1 Global Radiotheranostics Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Radiotheranostics Industry Mergers and Acquisition Analysis
- 5.3 Global Radiotheranostics New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Radiotheranostics Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Radiotheranostics Industrial Dynamics
- 7.1.1 Global Radiotheranostics Market Drivers
- 7.1.2 Global Radiotheranostics Market Restrains
- 7.1.3 Global Radiotheranostics Market Opportunities
- 7.1.4 Global Radiotheranostics Market Trends
- 7.2 Radiotheranostics Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Radiotheranostics Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Radiotheranostics Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 COVID-19 Impact on Radiotheranostics Industry
- 7.4.1 Overall Impact of COVID-19 on Radiotheranostics Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.6 Consumer Preference Analysis for Radiotheranostics Market
- 7.7 Patent Analysis of Radiotheranostics
- 7.8 Radiotheranostics Industrial Chain Analysis
- 7.9 Manufacturing Cost Analysis
- 8.1 Transcode Therapeutics Inc
- 8.1.1 Transcode Therapeutics Inc Company Basic Information, and Sales Area
- 8.1.2 Transcode Therapeutics Inc Business Segment/ Overview
- 8.1.3 Transcode Therapeutics Inc Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 Transcode Therapeutics Inc Sales Revenue (2018-2022)
- 8.1.3.3 Transcode Therapeutics Inc Market Share (2018-2022)
- 8.1.4 Transcode Therapeutics Inc Recent Developments
- 8.1.5 Transcode Therapeutics Inc Business Strategy
- 8.1.6 Transcode Therapeutics Inc Management Change
- 8.1.7 Transcode Therapeutics Inc SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 Transcode Therapeutics Inc COVID-19 Impact Analysis
- 8.2 Curium Sas
- 8.2.1 Curium Sas Company Basic Information, and Sales Area
- 8.2.2 Curium Sas Business Segment/ Overview
- 8.2.3 Curium Sas Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 Curium Sas Sales Revenue (2018-2022)
- 8.2.3.3 Curium Sas Market Share (2018-2022)
- 8.2.4 Curium Sas Recent Developments
- 8.2.5 Curium Sas Business Strategy
- 8.2.6 Curium Sas Management Change
- 8.2.7 Curium Sas SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 Curium Sas COVID-19 Impact Analysis
- 8.3 Ge Healthcare Inc
- 8.3.1 Ge Healthcare Inc Company Basic Information, and Sales Area
- 8.3.2 Ge Healthcare Inc Business Segment/ Overview
- 8.3.3 Ge Healthcare Inc Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Ge Healthcare Inc Sales Revenue (2018-2022)
- 8.3.3.3 Ge Healthcare Inc Market Share (2018-2022)
- 8.3.4 Ge Healthcare Inc Recent Developments
- 8.3.5 Ge Healthcare Inc Business Strategy
- 8.3.6 Ge Healthcare Inc Management Change
- 8.3.7 Ge Healthcare Inc SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Ge Healthcare Inc COVID-19 Impact Analysis
- 8.4 Bayer Ag
- 8.4.1 Bayer Ag Company Basic Information, and Sales Area
- 8.4.2 Bayer Ag Business Segment/ Overview
- 8.4.3 Bayer Ag Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Bayer Ag Sales Revenue (2018-2022)
- 8.4.3.3 Bayer Ag Market Share (2018-2022)
- 8.4.4 Bayer Ag Recent Developments
- 8.4.5 Bayer Ag Business Strategy
- 8.4.6 Bayer Ag Management Change
- 8.4.7 Bayer Ag SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Bayer Ag COVID-19 Impact Analysis
- 8.5 Lantheus Medical
- 8.5.1 Lantheus Medical Company Basic Information, and Sales Area
- 8.5.2 Lantheus Medical Business Segment/ Overview
- 8.5.3 Lantheus Medical Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Lantheus Medical Sales Revenue (2018-2022)
- 8.5.3.3 Lantheus Medical Market Share (2018-2022)
- 8.5.4 Lantheus Medical Recent Developments
- 8.5.5 Lantheus Medical Business Strategy
- 8.5.6 Lantheus Medical Management Change
- 8.5.7 Lantheus Medical SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Lantheus Medical COVID-19 Impact Analysis
- 8.6 Imaging Inc
- 8.6.1 Imaging Inc Company Basic Information, and Sales Area
- 8.6.2 Imaging Inc Business Segment/ Overview
- 8.6.3 Imaging Inc Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 Imaging Inc Sales Revenue (2018-2022)
- 8.6.3.3 Imaging Inc Market Share (2018-2022)
- 8.6.4 Imaging Inc Recent Developments
- 8.6.5 Imaging Inc Business Strategy
- 8.6.6 Imaging Inc Management Change
- 8.6.7 Imaging Inc SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 Imaging Inc COVID-19 Impact Analysis
- 8.7 Novartis Ag
- 8.7.1 Novartis Ag Company Basic Information, and Sales Area
- 8.7.2 Novartis Ag Business Segment/ Overview
- 8.7.3 Novartis Ag Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Novartis Ag Sales Revenue (2018-2022)
- 8.7.3.3 Novartis Ag Market Share (2018-2022)
- 8.7.4 Novartis Ag Recent Developments
- 8.7.5 Novartis Ag Business Strategy
- 8.7.6 Novartis Ag Management Change
- 8.7.7 Novartis Ag SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Novartis Ag COVID-19 Impact Analysis
- 8.8 Spectrum Pharmaceuticals Inc
- 8.8.1 Spectrum Pharmaceuticals Inc Company Basic Information, and Sales Area
- 8.8.2 Spectrum Pharmaceuticals Inc Business Segment/ Overview
- 8.8.3 Spectrum Pharmaceuticals Inc Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 Spectrum Pharmaceuticals Inc Sales Revenue (2018-2022)
- 8.8.3.3 Spectrum Pharmaceuticals Inc Market Share (2018-2022)
- 8.8.4 Spectrum Pharmaceuticals Inc Recent Developments
- 8.8.5 Spectrum Pharmaceuticals Inc Business Strategy
- 8.8.6 Spectrum Pharmaceuticals Inc Management Change
- 8.8.7 Spectrum Pharmaceuticals Inc SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 Spectrum Pharmaceuticals Inc COVID-19 Impact Analysis
- 8.9 Ipsen Sa
- 8.9.1 Ipsen Sa Company Basic Information, and Sales Area
- 8.9.2 Ipsen Sa Business Segment/ Overview
- 8.9.3 Ipsen Sa Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 Ipsen Sa Sales Revenue (2018-2022)
- 8.9.3.3 Ipsen Sa Market Share (2018-2022)
- 8.9.4 Ipsen Sa Recent Developments
- 8.9.5 Ipsen Sa Business Strategy
- 8.9.6 Ipsen Sa Management Change
- 8.9.7 Ipsen Sa SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 Ipsen Sa COVID-19 Impact Analysis
- 8.10 Actinium Pharmaceuticals Inc (Atnm)
- 8.10.1 Actinium Pharmaceuticals Inc (Atnm) Company Basic Information, and Sales Area
- 8.10.2 Actinium Pharmaceuticals Inc (Atnm) Business Segment/ Overview
- 8.10.3 Actinium Pharmaceuticals Inc (Atnm) Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Actinium Pharmaceuticals Inc (Atnm) Sales Revenue (2018-2022)
- 8.10.3.3 Actinium Pharmaceuticals Inc (Atnm) Market Share (2018-2022)
- 8.10.4 Actinium Pharmaceuticals Inc (Atnm) Recent Developments
- 8.10.5 Actinium Pharmaceuticals Inc (Atnm) Business Strategy
- 8.10.6 Actinium Pharmaceuticals Inc (Atnm) Management Change
- 8.10.7 Actinium Pharmaceuticals Inc (Atnm) SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Actinium Pharmaceuticals Inc (Atnm) COVID-19 Impact Analysis
- 8.11 Nordic Nanovector Asa
- 8.11.1 Nordic Nanovector Asa Company Basic Information, and Sales Area
- 8.11.2 Nordic Nanovector Asa Business Segment/ Overview
- 8.11.3 Nordic Nanovector Asa Financials
- 8.11.3.1 Investment in Research and Development
- 8.11.3.2 Nordic Nanovector Asa Sales Revenue (2018-2022)
- 8.11.3.3 Nordic Nanovector Asa Market Share (2018-2022)
- 8.11.4 Nordic Nanovector Asa Recent Developments
- 8.11.5 Nordic Nanovector Asa Business Strategy
- 8.11.6 Nordic Nanovector Asa Management Change
- 8.11.7 Nordic Nanovector Asa SWOT Analysis
- 8.11.7.1 Strength
- 8.11.7.2 Weakness
- 8.11.7.3 Opportunity
- 8.11.7.4 Threats
- 8.11.8 Nordic Nanovector Asa COVID-19 Impact Analysis
- 8.12 Y-Mabs Therapeutics Inc
- 8.12.1 Y-Mabs Therapeutics Inc Company Basic Information, and Sales Area
- 8.12.2 Y-Mabs Therapeutics Inc Business Segment/ Overview
- 8.12.3 Y-Mabs Therapeutics Inc Financials
- 8.12.3.1 Investment in Research and Development
- 8.12.3.2 Y-Mabs Therapeutics Inc Sales Revenue (2018-2022)
- 8.12.3.3 Y-Mabs Therapeutics Inc Market Share (2018-2022)
- 8.12.4 Y-Mabs Therapeutics Inc Recent Developments
- 8.12.5 Y-Mabs Therapeutics Inc Business Strategy
- 8.12.6 Y-Mabs Therapeutics Inc Management Change
- 8.12.7 Y-Mabs Therapeutics Inc SWOT Analysis
- 8.12.7.1 Strength
- 8.12.7.2 Weakness
- 8.12.7.3 Opportunity
- 8.12.7.4 Threats
- 8.12.8 Y-Mabs Therapeutics Inc COVID-19 Impact Analysis
- 8.13 Sofie Biosciences Inc
- 8.13.1 Sofie Biosciences Inc Company Basic Information, and Sales Area
- 8.13.2 Sofie Biosciences Inc Business Segment/ Overview
- 8.13.3 Sofie Biosciences Inc Financials
- 8.13.3.1 Investment in Research and Development
- 8.13.3.2 Sofie Biosciences Inc Sales Revenue (2018-2022)
- 8.13.3.3 Sofie Biosciences Inc Market Share (2018-2022)
- 8.13.4 Sofie Biosciences Inc Recent Developments
- 8.13.5 Sofie Biosciences Inc Business Strategy
- 8.13.6 Sofie Biosciences Inc Management Change
- 8.13.7 Sofie Biosciences Inc SWOT Analysis
- 8.13.7.1 Strength
- 8.13.7.2 Weakness
- 8.13.7.3 Opportunity
- 8.13.7.4 Threats
- 8.13.8 Sofie Biosciences Inc COVID-19 Impact Analysis
- 8.14 Terumo Corporation
- 8.14.1 Terumo Corporation Company Basic Information, and Sales Area
- 8.14.2 Terumo Corporation Business Segment/ Overview
- 8.14.3 Terumo Corporation Financials
- 8.14.3.1 Investment in Research and Development
- 8.14.3.2 Terumo Corporation Sales Revenue (2018-2022)
- 8.14.3.3 Terumo Corporation Market Share (2018-2022)
- 8.14.4 Terumo Corporation Recent Developments
- 8.14.5 Terumo Corporation Business Strategy
- 8.14.6 Terumo Corporation Management Change
- 8.14.7 Terumo Corporation SWOT Analysis
- 8.14.7.1 Strength
- 8.14.7.2 Weakness
- 8.14.7.3 Opportunity
- 8.14.7.4 Threats
- 8.14.8 Terumo Corporation COVID-19 Impact Analysis
- 8.15 Sirtex Medical Limited
- 8.15.1 Sirtex Medical Limited Company Basic Information, and Sales Area
- 8.15.2 Sirtex Medical Limited Business Segment/ Overview
- 8.15.3 Sirtex Medical Limited Financials
- 8.15.3.1 Investment in Research and Development
- 8.15.3.2 Sirtex Medical Limited Sales Revenue (2018-2022)
- 8.15.3.3 Sirtex Medical Limited Market Share (2018-2022)
- 8.15.4 Sirtex Medical Limited Recent Developments
- 8.15.5 Sirtex Medical Limited Business Strategy
- 8.15.6 Sirtex Medical Limited Management Change
- 8.15.7 Sirtex Medical Limited SWOT Analysis
- 8.15.7.1 Strength
- 8.15.7.2 Weakness
- 8.15.7.3 Opportunity
- 8.15.7.4 Threats
- 8.15.8 Sirtex Medical Limited COVID-19 Impact Analysis
- 8.16 Boston Scientific Corporation
- 8.16.1 Boston Scientific Corporation Company Basic Information, and Sales Area
- 8.16.2 Boston Scientific Corporation Business Segment/ Overview
- 8.16.3 Boston Scientific Corporation Financials
- 8.16.3.1 Investment in Research and Development
- 8.16.3.2 Boston Scientific Corporation Sales Revenue (2018-2022)
- 8.16.3.3 Boston Scientific Corporation Market Share (2018-2022)
- 8.16.4 Boston Scientific Corporation Recent Developments
- 8.16.5 Boston Scientific Corporation Business Strategy
- 8.16.6 Boston Scientific Corporation Management Change
- 8.16.7 Boston Scientific Corporation SWOT Analysis
- 8.16.7.1 Strength
- 8.16.7.2 Weakness
- 8.16.7.3 Opportunity
- 8.16.7.4 Threats
- 8.16.8 Boston Scientific Corporation COVID-19 Impact Analysis
- 8.17 Nihon Medi-Physics
- 8.17.1 Nihon Medi-Physics Company Basic Information, and Sales Area
- 8.17.2 Nihon Medi-Physics Business Segment/ Overview
- 8.17.3 Nihon Medi-Physics Financials
- 8.17.3.1 Investment in Research and Development
- 8.17.3.2 Nihon Medi-Physics Sales Revenue (2018-2022)
- 8.17.3.3 Nihon Medi-Physics Market Share (2018-2022)
- 8.17.4 Nihon Medi-Physics Recent Developments
- 8.17.5 Nihon Medi-Physics Business Strategy
- 8.17.6 Nihon Medi-Physics Management Change
- 8.17.7 Nihon Medi-Physics SWOT Analysis
- 8.17.7.1 Strength
- 8.17.7.2 Weakness
- 8.17.7.3 Opportunity
- 8.17.7.4 Threats
- 8.17.8 Nihon Medi-Physics COVID-19 Impact Analysis
- 8.18 Itm Isotopen Technologien München Ag
- 8.18.1 Itm Isotopen Technologien München Ag Company Basic Information, and Sales Area
- 8.18.2 Itm Isotopen Technologien München Ag Business Segment/ Overview
- 8.18.3 Itm Isotopen Technologien München Ag Financials
- 8.18.3.1 Investment in Research and Development
- 8.18.3.2 Itm Isotopen Technologien München Ag Sales Revenue (2018-2022)
- 8.18.3.3 Itm Isotopen Technologien München Ag Market Share (2018-2022)
- 8.18.4 Itm Isotopen Technologien München Ag Recent Developments
- 8.18.5 Itm Isotopen Technologien München Ag Business Strategy
- 8.18.6 Itm Isotopen Technologien München Ag Management Change
- 8.18.7 Itm Isotopen Technologien München Ag SWOT Analysis
- 8.18.7.1 Strength
- 8.18.7.2 Weakness
- 8.18.7.3 Opportunity
- 8.18.7.4 Threats
- 8.18.8 Itm Isotopen Technologien München Ag COVID-19 Impact Analysis
- 8.19 Advanced Accelerator Applications
- 8.19.1 Advanced Accelerator Applications Company Basic Information, and Sales Area
- 8.19.2 Advanced Accelerator Applications Business Segment/ Overview
- 8.19.3 Advanced Accelerator Applications Financials
- 8.19.3.1 Investment in Research and Development
- 8.19.3.2 Advanced Accelerator Applications Sales Revenue (2018-2022)
- 8.19.3.3 Advanced Accelerator Applications Market Share (2018-2022)
- 8.19.4 Advanced Accelerator Applications Recent Developments
- 8.19.5 Advanced Accelerator Applications Business Strategy
- 8.19.6 Advanced Accelerator Applications Management Change
- 8.19.7 Advanced Accelerator Applications SWOT Analysis
- 8.19.7.1 Strength
- 8.19.7.2 Weakness
- 8.19.7.3 Opportunity
- 8.19.7.4 Threats
- 8.19.8 Advanced Accelerator Applications COVID-19 Impact Analysis
- 8.20 Telix Pharmaceuticals
- 8.20.1 Telix Pharmaceuticals Company Basic Information, and Sales Area
- 8.20.2 Telix Pharmaceuticals Business Segment/ Overview
- 8.20.3 Telix Pharmaceuticals Financials
- 8.20.3.1 Investment in Research and Development
- 8.20.3.2 Telix Pharmaceuticals Sales Revenue (2018-2022)
- 8.20.3.3 Telix Pharmaceuticals Market Share (2018-2022)
- 8.20.4 Telix Pharmaceuticals Recent Developments
- 8.20.5 Telix Pharmaceuticals Business Strategy
- 8.20.6 Telix Pharmaceuticals Management Change
- 8.20.7 Telix Pharmaceuticals SWOT Analysis
- 8.20.7.1 Strength
- 8.20.7.2 Weakness
- 8.20.7.3 Opportunity
- 8.20.7.4 Threats
- 8.20.8 Telix Pharmaceuticals COVID-19 Impact Analysis
- 8.21 Theragnostics Ltd
- 8.21.1 Theragnostics Ltd Company Basic Information, and Sales Area
- 8.21.2 Theragnostics Ltd Business Segment/ Overview
- 8.21.3 Theragnostics Ltd Financials
- 8.21.3.1 Investment in Research and Development
- 8.21.3.2 Theragnostics Ltd Sales Revenue (2018-2022)
- 8.21.3.3 Theragnostics Ltd Market Share (2018-2022)
- 8.21.4 Theragnostics Ltd Recent Developments
- 8.21.5 Theragnostics Ltd Business Strategy
- 8.21.6 Theragnostics Ltd Management Change
- 8.21.7 Theragnostics Ltd SWOT Analysis
- 8.21.7.1 Strength
- 8.21.7.2 Weakness
- 8.21.7.3 Opportunity
- 8.21.7.4 Threats
- 8.21.8 Theragnostics Ltd COVID-19 Impact Analysis
- 8.22 Nuview Life Sciences
- 8.22.1 Nuview Life Sciences Company Basic Information, and Sales Area
- 8.22.2 Nuview Life Sciences Business Segment/ Overview
- 8.22.3 Nuview Life Sciences Financials
- 8.22.3.1 Investment in Research and Development
- 8.22.3.2 Nuview Life Sciences Sales Revenue (2018-2022)
- 8.22.3.3 Nuview Life Sciences Market Share (2018-2022)
- 8.22.4 Nuview Life Sciences Recent Developments
- 8.22.5 Nuview Life Sciences Business Strategy
- 8.22.6 Nuview Life Sciences Management Change
- 8.22.7 Nuview Life Sciences SWOT Analysis
- 8.22.7.1 Strength
- 8.22.7.2 Weakness
- 8.22.7.3 Opportunity
- 8.22.7.4 Threats
- 8.22.8 Nuview Life Sciences COVID-19 Impact Analysis
- 8.23 Jubilant Pharma Limited
- 8.23.1 Jubilant Pharma Limited Company Basic Information, and Sales Area
- 8.23.2 Jubilant Pharma Limited Business Segment/ Overview
- 8.23.3 Jubilant Pharma Limited Financials
- 8.23.3.1 Investment in Research and Development
- 8.23.3.2 Jubilant Pharma Limited Sales Revenue (2018-2022)
- 8.23.3.3 Jubilant Pharma Limited Market Share (2018-2022)
- 8.23.4 Jubilant Pharma Limited Recent Developments
- 8.23.5 Jubilant Pharma Limited Business Strategy
- 8.23.6 Jubilant Pharma Limited Management Change
- 8.23.7 Jubilant Pharma Limited SWOT Analysis
- 8.23.7.1 Strength
- 8.23.7.2 Weakness
- 8.23.7.3 Opportunity
- 8.23.7.4 Threats
- 8.23.8 Jubilant Pharma Limited COVID-19 Impact Analysis
- 8.24 Clarity Pharmaceuticals
- 8.24.1 Clarity Pharmaceuticals Company Basic Information, and Sales Area
- 8.24.2 Clarity Pharmaceuticals Business Segment/ Overview
- 8.24.3 Clarity Pharmaceuticals Financials
- 8.24.3.1 Investment in Research and Development
- 8.24.3.2 Clarity Pharmaceuticals Sales Revenue (2018-2022)
- 8.24.3.3 Clarity Pharmaceuticals Market Share (2018-2022)
- 8.24.4 Clarity Pharmaceuticals Recent Developments
- 8.24.5 Clarity Pharmaceuticals Business Strategy
- 8.24.6 Clarity Pharmaceuticals Management Change
- 8.24.7 Clarity Pharmaceuticals SWOT Analysis
- 8.24.7.1 Strength
- 8.24.7.2 Weakness
- 8.24.7.3 Opportunity
- 8.24.7.4 Threats
- 8.24.8 Clarity Pharmaceuticals COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Radiotheranostics Revenue and Share (%) by Radioisotope (2018-2030)
- 9.2.1 Technetium-99 Market Size
- 9.2.1.1 Global Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Radiotheranostics Market for Technetium-99, by Country (2021 Vs 2024)
- 9.2.2 Gallium-68 Market Size
- 9.2.2.1 Global Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Radiotheranostics Market for Gallium-68, by Country (2021 Vs 2024)
- 9.2.3 Iodine-131 Market Size
- 9.2.3.1 Global Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Radiotheranostics Market for Iodine-131, by Country (2021 Vs 2024)
- 9.2.4 Iodine-123 Market Size
- 9.2.4.1 Global Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.4.2 Radiotheranostics Market for Iodine-123, by Country (2021 Vs 2024)
- 9.2.5 18F Market Size
- 9.2.5.1 Global 18F Market Share and Revenue (USD Million) for 2018-2030
- 9.2.5.2 Radiotheranostics Market for 18F, by Country (2021 Vs 2024)
- 9.2.6 y-90 Market Size
- 9.2.6.1 Global y-90 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.6.2 Radiotheranostics Market for y-90, by Country (2021 Vs 2024)
- 9.2.7 Lutetium (lu) 177 Market Size
- 9.2.7.1 Global Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.7.2 Radiotheranostics Market for Lutetium (lu) 177, by Country (2021 Vs 2024)
- 9.2.8 Copper (Cu) 67 Market Size
- 9.2.8.1 Global Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.8.2 Radiotheranostics Market for Copper (Cu) 67, by Country (2021 Vs 2024)
- 9.2.9 Copper (Cu) 64 Market Size
- 9.2.9.1 Global Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 9.2.9.2 Radiotheranostics Market for Copper (Cu) 64, by Country (2021 Vs 2024)
- 9.2.10 Others Market Size
- 9.2.10.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 9.2.10.2 Radiotheranostics Market for Others, by Country (2021 Vs 2024)
- 9.2.1 Technetium-99 Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Radiotheranostics Revenue and Share (%) by Application (2018-2030)
- 10.2.1 Oncology Market Size
- 10.2.1.1 Global Oncology Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Radiotheranostics Market for Oncology, by Country (2021 Vs 2024)
- 10.2.2 Non-oncology Market Size
- 10.2.2.1 Global Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Radiotheranostics Market for Non-oncology, by Country (2021 Vs 2024)
- 10.2.1 Oncology Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Radiotheranostics Revenue and Share (%) by Source (2018-2030)
- 11.2.1 Nuclear Reactors Market Size
- 11.2.1.1 Global Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Radiotheranostics Market for Nuclear Reactors, by Country (2021 Vs 2024)
- 11.2.2 Cyclotrons Market Size
- 11.2.2.1 Global Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Radiotheranostics Market for Cyclotrons, by Country (2021 Vs 2024)
- 11.2.1 Nuclear Reactors Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Radiotheranostics Revenue and Share (%) by Approach (2018-2030)
- 12.2.1 Targeted Therapeutic (Rx) Market Size
- 12.2.1.1 Global Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.2 Radiotheranostics Market for Targeted Therapeutic (Rx), by Country (2021 Vs 2024)
- 12.2.2 Companion Diagnostic (DX) Market Size
- 12.2.2.1 Global Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 12.2.2.2 Radiotheranostics Market for Companion Diagnostic (DX), by Country (2021 Vs 2024)
- 12.2.1 Targeted Therapeutic (Rx) Market Size
- 13.1 Detailed Qualitative Analysis
- 13.2 Global Radiotheranostics Revenue and Share (%) by End-User (2018-2030)
- 13.2.1 Hospitals & clinics Market Size
- 13.2.1.1 Global Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Radiotheranostics Market for Hospitals & clinics, by Country (2021 Vs 2024)
- 13.2.2 Pharmaceutical & biotechnology companies Market Size
- 13.2.2.1 Global Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Radiotheranostics Market for Pharmaceutical & biotechnology companies, by Country (2021 Vs 2024)
- 13.2.3 Others Market Size
- 13.2.3.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Radiotheranostics Market for Others, by Country (2021 Vs 2024)
- 13.2.1 Hospitals & clinics Market Size
- 14.1 Detailed Qualitative Analysis
- 14.2 Global Radiotheranostics Market Revenue by Region (2018-2030)
- 14.3 Global Radiotheranostics Market Share (%) by Region (2018-2030)
- 15.1 North America
- 15.1.1 North America Radiotheranostics Market Trends and Analysis
- 15.1.2 North America Radiotheranostics Market by Country, 2018-2030
- 15.1.3 North America Radiotheranostics Market Attractiveness Analysis by Country
- 15.2 North America Radiotheranostics Market Size (2018-2030)
- 15.2.1 North America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.2.1.1 Technetium-99
- 15.2.1.1.1 North America Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Gallium-68
- 15.2.1.2.1 North America Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Iodine-131
- 15.2.1.3.1 North America Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Iodine-123
- 15.2.1.4.1 North America Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.5 18F
- 15.2.1.5.1 North America 18F Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.6 y-90
- 15.2.1.6.1 North America y-90 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.7 Lutetium (lu) 177
- 15.2.1.7.1 North America Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.8 Copper (Cu) 67
- 15.2.1.8.1 North America Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.9 Copper (Cu) 64
- 15.2.1.9.1 North America Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.10 Others
- 15.2.1.10.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Technetium-99
- 15.2.2 North America Radiotheranostics Market (USD Million) by Application (2018-2030)
- 15.2.2.1 Oncology
- 15.2.2.1.1 North America Oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Non-oncology
- 15.2.2.2.1 North America Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Oncology
- 15.2.3 North America Radiotheranostics Market (USD Million) by Source (2018-2030)
- 15.2.3.1 Nuclear Reactors
- 15.2.3.1.1 North America Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Cyclotrons
- 15.2.3.2.1 North America Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 Nuclear Reactors
- 15.2.4 North America Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 15.2.4.1 Targeted Therapeutic (Rx)
- 15.2.4.1.1 North America Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 15.2.4.2 Companion Diagnostic (DX)
- 15.2.4.2.1 North America Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 15.2.4.1 Targeted Therapeutic (Rx)
- 15.2.5 North America Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 15.2.5.1 Hospitals & clinics
- 15.2.5.1.1 North America Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 15.2.5.2 Pharmaceutical & biotechnology companies
- 15.2.5.2.1 North America Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 15.2.5.3 Others
- 15.2.5.3.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.5.1 Hospitals & clinics
- 15.2.1 North America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.3 United States Radiotheranostics Market Size (2018-2030)
- 15.3.1 United States Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.3.1.1 Technetium-99
- 15.3.1.1.1 United States Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.2 Gallium-68
- 15.3.1.2.1 United States Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.3 Iodine-131
- 15.3.1.3.1 United States Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.4 Iodine-123
- 15.3.1.4.1 United States Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.5 18F
- 15.3.1.5.1 United States 18F Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.6 y-90
- 15.3.1.6.1 United States y-90 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.7 Lutetium (lu) 177
- 15.3.1.7.1 United States Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.8 Copper (Cu) 67
- 15.3.1.8.1 United States Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.9 Copper (Cu) 64
- 15.3.1.9.1 United States Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.10 Others
- 15.3.1.10.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.1 Technetium-99
- 15.3.2 United States Radiotheranostics Market (USD Million) by Application (2018-2030)
- 15.3.2.1 Oncology
- 15.3.2.1.1 United States Oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.2 Non-oncology
- 15.3.2.2.1 United States Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.1 Oncology
- 15.3.3 United States Radiotheranostics Market (USD Million) by Source (2018-2030)
- 15.3.3.1 Nuclear Reactors
- 15.3.3.1.1 United States Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.2 Cyclotrons
- 15.3.3.2.1 United States Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.1 Nuclear Reactors
- 15.3.4 United States Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 15.3.4.1 Targeted Therapeutic (Rx)
- 15.3.4.1.1 United States Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 15.3.4.2 Companion Diagnostic (DX)
- 15.3.4.2.1 United States Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 15.3.4.1 Targeted Therapeutic (Rx)
- 15.3.5 United States Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 15.3.5.1 Hospitals & clinics
- 15.3.5.1.1 United States Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 15.3.5.2 Pharmaceutical & biotechnology companies
- 15.3.5.2.1 United States Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 15.3.5.3 Others
- 15.3.5.3.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 15.3.5.1 Hospitals & clinics
- 15.3.1 United States Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.4 Canada Radiotheranostics Market Size (2018-2030)
- 15.4.1 Canada Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.4.1.1 Technetium-99
- 15.4.1.1.1 Canada Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.2 Gallium-68
- 15.4.1.2.1 Canada Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.3 Iodine-131
- 15.4.1.3.1 Canada Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.4 Iodine-123
- 15.4.1.4.1 Canada Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.5 18F
- 15.4.1.5.1 Canada 18F Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.6 y-90
- 15.4.1.6.1 Canada y-90 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.7 Lutetium (lu) 177
- 15.4.1.7.1 Canada Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.8 Copper (Cu) 67
- 15.4.1.8.1 Canada Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.9 Copper (Cu) 64
- 15.4.1.9.1 Canada Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.10 Others
- 15.4.1.10.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.1 Technetium-99
- 15.4.2 Canada Radiotheranostics Market (USD Million) by Application (2018-2030)
- 15.4.2.1 Oncology
- 15.4.2.1.1 Canada Oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.2 Non-oncology
- 15.4.2.2.1 Canada Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.1 Oncology
- 15.4.3 Canada Radiotheranostics Market (USD Million) by Source (2018-2030)
- 15.4.3.1 Nuclear Reactors
- 15.4.3.1.1 Canada Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.2 Cyclotrons
- 15.4.3.2.1 Canada Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.1 Nuclear Reactors
- 15.4.4 Canada Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 15.4.4.1 Targeted Therapeutic (Rx)
- 15.4.4.1.1 Canada Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 15.4.4.2 Companion Diagnostic (DX)
- 15.4.4.2.1 Canada Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 15.4.4.1 Targeted Therapeutic (Rx)
- 15.4.5 Canada Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 15.4.5.1 Hospitals & clinics
- 15.4.5.1.1 Canada Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 15.4.5.2 Pharmaceutical & biotechnology companies
- 15.4.5.2.1 Canada Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 15.4.5.3 Others
- 15.4.5.3.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 15.4.5.1 Hospitals & clinics
- 15.4.1 Canada Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.5 Mexico Radiotheranostics Market Size (2018-2030)
- 15.5.1 Mexico Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 15.5.1.1 Technetium-99
- 15.5.1.1.1 Mexico Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.2 Gallium-68
- 15.5.1.2.1 Mexico Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.3 Iodine-131
- 15.5.1.3.1 Mexico Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.4 Iodine-123
- 15.5.1.4.1 Mexico Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.5 18F
- 15.5.1.5.1 Mexico 18F Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.6 y-90
- 15.5.1.6.1 Mexico y-90 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.7 Lutetium (lu) 177
- 15.5.1.7.1 Mexico Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.8 Copper (Cu) 67
- 15.5.1.8.1 Mexico Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.9 Copper (Cu) 64
- 15.5.1.9.1 Mexico Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.10 Others
- 15.5.1.10.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.1 Technetium-99
- 15.5.2 Mexico Radiotheranostics Market (USD Million) by Application (2018-2030)
- 15.5.2.1 Oncology
- 15.5.2.1.1 Mexico Oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.2 Non-oncology
- 15.5.2.2.1 Mexico Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.1 Oncology
- 15.5.3 Mexico Radiotheranostics Market (USD Million) by Source (2018-2030)
- 15.5.3.1 Nuclear Reactors
- 15.5.3.1.1 Mexico Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.2 Cyclotrons
- 15.5.3.2.1 Mexico Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.1 Nuclear Reactors
- 15.5.4 Mexico Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 15.5.4.1 Targeted Therapeutic (Rx)
- 15.5.4.1.1 Mexico Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 15.5.4.2 Companion Diagnostic (DX)
- 15.5.4.2.1 Mexico Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 15.5.4.1 Targeted Therapeutic (Rx)
- 15.5.5 Mexico Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 15.5.5.1 Hospitals & clinics
- 15.5.5.1.1 Mexico Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 15.5.5.2 Pharmaceutical & biotechnology companies
- 15.5.5.2.1 Mexico Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 15.5.5.3 Others
- 15.5.5.3.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 15.5.5.1 Hospitals & clinics
- 15.5.1 Mexico Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.1 Europe
- 16.1.1 Europe Radiotheranostics Market Trends and Analysis
- 16.1.2 Europe Radiotheranostics Market by Country, 2018-2030
- 16.1.3 Europe Radiotheranostics Market Attractiveness Analysis by Country
- 16.2 Europe Radiotheranostics Market Size (2018-2030)
- 16.2.1 Europe Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.2.1.1 Technetium-99
- 16.2.1.1.1 Europe Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Gallium-68
- 16.2.1.2.1 Europe Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Iodine-131
- 16.2.1.3.1 Europe Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Iodine-123
- 16.2.1.4.1 Europe Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.5 18F
- 16.2.1.5.1 Europe 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.6 y-90
- 16.2.1.6.1 Europe y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.7 Lutetium (lu) 177
- 16.2.1.7.1 Europe Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.8 Copper (Cu) 67
- 16.2.1.8.1 Europe Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.9 Copper (Cu) 64
- 16.2.1.9.1 Europe Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.10 Others
- 16.2.1.10.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Technetium-99
- 16.2.2 Europe Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.2.2.1 Oncology
- 16.2.2.1.1 Europe Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Non-oncology
- 16.2.2.2.1 Europe Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Oncology
- 16.2.3 Europe Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.2.3.1 Nuclear Reactors
- 16.2.3.1.1 Europe Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Cyclotrons
- 16.2.3.2.1 Europe Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 Nuclear Reactors
- 16.2.4 Europe Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.2.4.1 Targeted Therapeutic (Rx)
- 16.2.4.1.1 Europe Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.2 Companion Diagnostic (DX)
- 16.2.4.2.1 Europe Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.1 Targeted Therapeutic (Rx)
- 16.2.5 Europe Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.2.5.1 Hospitals & clinics
- 16.2.5.1.1 Europe Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.2 Pharmaceutical & biotechnology companies
- 16.2.5.2.1 Europe Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.3 Others
- 16.2.5.3.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.1 Hospitals & clinics
- 16.2.1 Europe Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.3 United Kingdom Radiotheranostics Market Size (2018-2030)
- 16.3.1 United Kingdom Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.3.1.1 Technetium-99
- 16.3.1.1.1 United Kingdom Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.2 Gallium-68
- 16.3.1.2.1 United Kingdom Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.3 Iodine-131
- 16.3.1.3.1 United Kingdom Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.4 Iodine-123
- 16.3.1.4.1 United Kingdom Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.5 18F
- 16.3.1.5.1 United Kingdom 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.6 y-90
- 16.3.1.6.1 United Kingdom y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.7 Lutetium (lu) 177
- 16.3.1.7.1 United Kingdom Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.8 Copper (Cu) 67
- 16.3.1.8.1 United Kingdom Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.9 Copper (Cu) 64
- 16.3.1.9.1 United Kingdom Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.10 Others
- 16.3.1.10.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.1 Technetium-99
- 16.3.2 United Kingdom Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.3.2.1 Oncology
- 16.3.2.1.1 United Kingdom Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.2 Non-oncology
- 16.3.2.2.1 United Kingdom Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.1 Oncology
- 16.3.3 United Kingdom Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.3.3.1 Nuclear Reactors
- 16.3.3.1.1 United Kingdom Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.2 Cyclotrons
- 16.3.3.2.1 United Kingdom Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.1 Nuclear Reactors
- 16.3.4 United Kingdom Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.3.4.1 Targeted Therapeutic (Rx)
- 16.3.4.1.1 United Kingdom Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.2 Companion Diagnostic (DX)
- 16.3.4.2.1 United Kingdom Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.1 Targeted Therapeutic (Rx)
- 16.3.5 United Kingdom Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.3.5.1 Hospitals & clinics
- 16.3.5.1.1 United Kingdom Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.2 Pharmaceutical & biotechnology companies
- 16.3.5.2.1 United Kingdom Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.3 Others
- 16.3.5.3.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.1 Hospitals & clinics
- 16.3.1 United Kingdom Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.4 France Radiotheranostics Market Size (2018-2030)
- 16.4.1 France Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.4.1.1 Technetium-99
- 16.4.1.1.1 France Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.2 Gallium-68
- 16.4.1.2.1 France Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.3 Iodine-131
- 16.4.1.3.1 France Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.4 Iodine-123
- 16.4.1.4.1 France Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.5 18F
- 16.4.1.5.1 France 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.6 y-90
- 16.4.1.6.1 France y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.7 Lutetium (lu) 177
- 16.4.1.7.1 France Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.8 Copper (Cu) 67
- 16.4.1.8.1 France Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.9 Copper (Cu) 64
- 16.4.1.9.1 France Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.10 Others
- 16.4.1.10.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.1 Technetium-99
- 16.4.2 France Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.4.2.1 Oncology
- 16.4.2.1.1 France Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.2 Non-oncology
- 16.4.2.2.1 France Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.1 Oncology
- 16.4.3 France Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.4.3.1 Nuclear Reactors
- 16.4.3.1.1 France Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.2 Cyclotrons
- 16.4.3.2.1 France Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.1 Nuclear Reactors
- 16.4.4 France Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.4.4.1 Targeted Therapeutic (Rx)
- 16.4.4.1.1 France Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.2 Companion Diagnostic (DX)
- 16.4.4.2.1 France Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.1 Targeted Therapeutic (Rx)
- 16.4.5 France Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.4.5.1 Hospitals & clinics
- 16.4.5.1.1 France Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.2 Pharmaceutical & biotechnology companies
- 16.4.5.2.1 France Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.3 Others
- 16.4.5.3.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.1 Hospitals & clinics
- 16.4.1 France Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.5 Germany Radiotheranostics Market Size (2018-2030)
- 16.5.1 Germany Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.5.1.1 Technetium-99
- 16.5.1.1.1 Germany Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.2 Gallium-68
- 16.5.1.2.1 Germany Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.3 Iodine-131
- 16.5.1.3.1 Germany Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.4 Iodine-123
- 16.5.1.4.1 Germany Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.5 18F
- 16.5.1.5.1 Germany 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.6 y-90
- 16.5.1.6.1 Germany y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.7 Lutetium (lu) 177
- 16.5.1.7.1 Germany Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.8 Copper (Cu) 67
- 16.5.1.8.1 Germany Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.9 Copper (Cu) 64
- 16.5.1.9.1 Germany Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.10 Others
- 16.5.1.10.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.1 Technetium-99
- 16.5.2 Germany Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.5.2.1 Oncology
- 16.5.2.1.1 Germany Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.2 Non-oncology
- 16.5.2.2.1 Germany Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.1 Oncology
- 16.5.3 Germany Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.5.3.1 Nuclear Reactors
- 16.5.3.1.1 Germany Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.2 Cyclotrons
- 16.5.3.2.1 Germany Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.1 Nuclear Reactors
- 16.5.4 Germany Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.5.4.1 Targeted Therapeutic (Rx)
- 16.5.4.1.1 Germany Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.2 Companion Diagnostic (DX)
- 16.5.4.2.1 Germany Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.1 Targeted Therapeutic (Rx)
- 16.5.5 Germany Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.5.5.1 Hospitals & clinics
- 16.5.5.1.1 Germany Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.2 Pharmaceutical & biotechnology companies
- 16.5.5.2.1 Germany Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.3 Others
- 16.5.5.3.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.1 Hospitals & clinics
- 16.5.1 Germany Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.6 Italy Radiotheranostics Market Size (2018-2030)
- 16.6.1 Italy Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.6.1.1 Technetium-99
- 16.6.1.1.1 Italy Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.2 Gallium-68
- 16.6.1.2.1 Italy Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.3 Iodine-131
- 16.6.1.3.1 Italy Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.4 Iodine-123
- 16.6.1.4.1 Italy Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.5 18F
- 16.6.1.5.1 Italy 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.6 y-90
- 16.6.1.6.1 Italy y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.7 Lutetium (lu) 177
- 16.6.1.7.1 Italy Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.8 Copper (Cu) 67
- 16.6.1.8.1 Italy Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.9 Copper (Cu) 64
- 16.6.1.9.1 Italy Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.10 Others
- 16.6.1.10.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.1 Technetium-99
- 16.6.2 Italy Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.6.2.1 Oncology
- 16.6.2.1.1 Italy Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.2 Non-oncology
- 16.6.2.2.1 Italy Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.1 Oncology
- 16.6.3 Italy Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.6.3.1 Nuclear Reactors
- 16.6.3.1.1 Italy Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.2 Cyclotrons
- 16.6.3.2.1 Italy Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.1 Nuclear Reactors
- 16.6.4 Italy Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.6.4.1 Targeted Therapeutic (Rx)
- 16.6.4.1.1 Italy Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.6.4.2 Companion Diagnostic (DX)
- 16.6.4.2.1 Italy Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.6.4.1 Targeted Therapeutic (Rx)
- 16.6.5 Italy Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.6.5.1 Hospitals & clinics
- 16.6.5.1.1 Italy Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.6.5.2 Pharmaceutical & biotechnology companies
- 16.6.5.2.1 Italy Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.6.5.3 Others
- 16.6.5.3.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 16.6.5.1 Hospitals & clinics
- 16.6.1 Italy Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.7 Russia Radiotheranostics Market Size (2018-2030)
- 16.7.1 Russia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.7.1.1 Technetium-99
- 16.7.1.1.1 Russia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.2 Gallium-68
- 16.7.1.2.1 Russia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.3 Iodine-131
- 16.7.1.3.1 Russia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.4 Iodine-123
- 16.7.1.4.1 Russia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.5 18F
- 16.7.1.5.1 Russia 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.6 y-90
- 16.7.1.6.1 Russia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.7 Lutetium (lu) 177
- 16.7.1.7.1 Russia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.8 Copper (Cu) 67
- 16.7.1.8.1 Russia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.9 Copper (Cu) 64
- 16.7.1.9.1 Russia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.10 Others
- 16.7.1.10.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.1 Technetium-99
- 16.7.2 Russia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.7.2.1 Oncology
- 16.7.2.1.1 Russia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.2 Non-oncology
- 16.7.2.2.1 Russia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.1 Oncology
- 16.7.3 Russia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.7.3.1 Nuclear Reactors
- 16.7.3.1.1 Russia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.2 Cyclotrons
- 16.7.3.2.1 Russia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.1 Nuclear Reactors
- 16.7.4 Russia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.7.4.1 Targeted Therapeutic (Rx)
- 16.7.4.1.1 Russia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.7.4.2 Companion Diagnostic (DX)
- 16.7.4.2.1 Russia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.7.4.1 Targeted Therapeutic (Rx)
- 16.7.5 Russia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.7.5.1 Hospitals & clinics
- 16.7.5.1.1 Russia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.7.5.2 Pharmaceutical & biotechnology companies
- 16.7.5.2.1 Russia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.7.5.3 Others
- 16.7.5.3.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.7.5.1 Hospitals & clinics
- 16.7.1 Russia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.8 Spain Radiotheranostics Market Size (2018-2030)
- 16.8.1 Spain Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.8.1.1 Technetium-99
- 16.8.1.1.1 Spain Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.2 Gallium-68
- 16.8.1.2.1 Spain Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.3 Iodine-131
- 16.8.1.3.1 Spain Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.4 Iodine-123
- 16.8.1.4.1 Spain Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.5 18F
- 16.8.1.5.1 Spain 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.6 y-90
- 16.8.1.6.1 Spain y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.7 Lutetium (lu) 177
- 16.8.1.7.1 Spain Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.8 Copper (Cu) 67
- 16.8.1.8.1 Spain Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.9 Copper (Cu) 64
- 16.8.1.9.1 Spain Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.10 Others
- 16.8.1.10.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.1 Technetium-99
- 16.8.2 Spain Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.8.2.1 Oncology
- 16.8.2.1.1 Spain Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.2 Non-oncology
- 16.8.2.2.1 Spain Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.1 Oncology
- 16.8.3 Spain Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.8.3.1 Nuclear Reactors
- 16.8.3.1.1 Spain Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.2 Cyclotrons
- 16.8.3.2.1 Spain Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.1 Nuclear Reactors
- 16.8.4 Spain Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.8.4.1 Targeted Therapeutic (Rx)
- 16.8.4.1.1 Spain Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.8.4.2 Companion Diagnostic (DX)
- 16.8.4.2.1 Spain Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.8.4.1 Targeted Therapeutic (Rx)
- 16.8.5 Spain Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.8.5.1 Hospitals & clinics
- 16.8.5.1.1 Spain Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.8.5.2 Pharmaceutical & biotechnology companies
- 16.8.5.2.1 Spain Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.8.5.3 Others
- 16.8.5.3.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 16.8.5.1 Hospitals & clinics
- 16.8.1 Spain Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.9 Sweden Radiotheranostics Market Size (2018-2030)
- 16.9.1 Sweden Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.9.1.1 Technetium-99
- 16.9.1.1.1 Sweden Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.2 Gallium-68
- 16.9.1.2.1 Sweden Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.3 Iodine-131
- 16.9.1.3.1 Sweden Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.4 Iodine-123
- 16.9.1.4.1 Sweden Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.5 18F
- 16.9.1.5.1 Sweden 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.6 y-90
- 16.9.1.6.1 Sweden y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.7 Lutetium (lu) 177
- 16.9.1.7.1 Sweden Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.8 Copper (Cu) 67
- 16.9.1.8.1 Sweden Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.9 Copper (Cu) 64
- 16.9.1.9.1 Sweden Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.10 Others
- 16.9.1.10.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.1 Technetium-99
- 16.9.2 Sweden Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.9.2.1 Oncology
- 16.9.2.1.1 Sweden Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.2 Non-oncology
- 16.9.2.2.1 Sweden Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.1 Oncology
- 16.9.3 Sweden Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.9.3.1 Nuclear Reactors
- 16.9.3.1.1 Sweden Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.2 Cyclotrons
- 16.9.3.2.1 Sweden Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.1 Nuclear Reactors
- 16.9.4 Sweden Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.9.4.1 Targeted Therapeutic (Rx)
- 16.9.4.1.1 Sweden Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.9.4.2 Companion Diagnostic (DX)
- 16.9.4.2.1 Sweden Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.9.4.1 Targeted Therapeutic (Rx)
- 16.9.5 Sweden Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.9.5.1 Hospitals & clinics
- 16.9.5.1.1 Sweden Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.9.5.2 Pharmaceutical & biotechnology companies
- 16.9.5.2.1 Sweden Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.9.5.3 Others
- 16.9.5.3.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 16.9.5.1 Hospitals & clinics
- 16.9.1 Sweden Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.10 Denmark Radiotheranostics Market Size (2018-2030)
- 16.10.1 Denmark Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.10.1.1 Technetium-99
- 16.10.1.1.1 Denmark Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.2 Gallium-68
- 16.10.1.2.1 Denmark Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.3 Iodine-131
- 16.10.1.3.1 Denmark Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.4 Iodine-123
- 16.10.1.4.1 Denmark Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.5 18F
- 16.10.1.5.1 Denmark 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.6 y-90
- 16.10.1.6.1 Denmark y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.7 Lutetium (lu) 177
- 16.10.1.7.1 Denmark Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.8 Copper (Cu) 67
- 16.10.1.8.1 Denmark Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.9 Copper (Cu) 64
- 16.10.1.9.1 Denmark Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.10 Others
- 16.10.1.10.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.1 Technetium-99
- 16.10.2 Denmark Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.10.2.1 Oncology
- 16.10.2.1.1 Denmark Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.2 Non-oncology
- 16.10.2.2.1 Denmark Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.1 Oncology
- 16.10.3 Denmark Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.10.3.1 Nuclear Reactors
- 16.10.3.1.1 Denmark Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.2 Cyclotrons
- 16.10.3.2.1 Denmark Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.1 Nuclear Reactors
- 16.10.4 Denmark Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.10.4.1 Targeted Therapeutic (Rx)
- 16.10.4.1.1 Denmark Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.10.4.2 Companion Diagnostic (DX)
- 16.10.4.2.1 Denmark Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.10.4.1 Targeted Therapeutic (Rx)
- 16.10.5 Denmark Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.10.5.1 Hospitals & clinics
- 16.10.5.1.1 Denmark Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.10.5.2 Pharmaceutical & biotechnology companies
- 16.10.5.2.1 Denmark Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.10.5.3 Others
- 16.10.5.3.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 16.10.5.1 Hospitals & clinics
- 16.10.1 Denmark Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.11 Netherlands Radiotheranostics Market Size (2018-2030)
- 16.11.1 Netherlands Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.11.1.1 Technetium-99
- 16.11.1.1.1 Netherlands Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.2 Gallium-68
- 16.11.1.2.1 Netherlands Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.3 Iodine-131
- 16.11.1.3.1 Netherlands Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.4 Iodine-123
- 16.11.1.4.1 Netherlands Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.5 18F
- 16.11.1.5.1 Netherlands 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.6 y-90
- 16.11.1.6.1 Netherlands y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.7 Lutetium (lu) 177
- 16.11.1.7.1 Netherlands Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.8 Copper (Cu) 67
- 16.11.1.8.1 Netherlands Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.9 Copper (Cu) 64
- 16.11.1.9.1 Netherlands Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.10 Others
- 16.11.1.10.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.1 Technetium-99
- 16.11.2 Netherlands Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.11.2.1 Oncology
- 16.11.2.1.1 Netherlands Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.11.2.2 Non-oncology
- 16.11.2.2.1 Netherlands Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.11.2.1 Oncology
- 16.11.3 Netherlands Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.11.3.1 Nuclear Reactors
- 16.11.3.1.1 Netherlands Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.2 Cyclotrons
- 16.11.3.2.1 Netherlands Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.1 Nuclear Reactors
- 16.11.4 Netherlands Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.11.4.1 Targeted Therapeutic (Rx)
- 16.11.4.1.1 Netherlands Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.11.4.2 Companion Diagnostic (DX)
- 16.11.4.2.1 Netherlands Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.11.4.1 Targeted Therapeutic (Rx)
- 16.11.5 Netherlands Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.11.5.1 Hospitals & clinics
- 16.11.5.1.1 Netherlands Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.11.5.2 Pharmaceutical & biotechnology companies
- 16.11.5.2.1 Netherlands Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.11.5.3 Others
- 16.11.5.3.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 16.11.5.1 Hospitals & clinics
- 16.11.1 Netherlands Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.12 Switzerland Radiotheranostics Market Size (2018-2030)
- 16.12.1 Switzerland Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.12.1.1 Technetium-99
- 16.12.1.1.1 Switzerland Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.2 Gallium-68
- 16.12.1.2.1 Switzerland Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.3 Iodine-131
- 16.12.1.3.1 Switzerland Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.4 Iodine-123
- 16.12.1.4.1 Switzerland Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.5 18F
- 16.12.1.5.1 Switzerland 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.6 y-90
- 16.12.1.6.1 Switzerland y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.7 Lutetium (lu) 177
- 16.12.1.7.1 Switzerland Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.8 Copper (Cu) 67
- 16.12.1.8.1 Switzerland Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.9 Copper (Cu) 64
- 16.12.1.9.1 Switzerland Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.10 Others
- 16.12.1.10.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.1 Technetium-99
- 16.12.2 Switzerland Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.12.2.1 Oncology
- 16.12.2.1.1 Switzerland Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.12.2.2 Non-oncology
- 16.12.2.2.1 Switzerland Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.12.2.1 Oncology
- 16.12.3 Switzerland Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.12.3.1 Nuclear Reactors
- 16.12.3.1.1 Switzerland Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.2 Cyclotrons
- 16.12.3.2.1 Switzerland Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.1 Nuclear Reactors
- 16.12.4 Switzerland Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.12.4.1 Targeted Therapeutic (Rx)
- 16.12.4.1.1 Switzerland Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.12.4.2 Companion Diagnostic (DX)
- 16.12.4.2.1 Switzerland Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.12.4.1 Targeted Therapeutic (Rx)
- 16.12.5 Switzerland Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.12.5.1 Hospitals & clinics
- 16.12.5.1.1 Switzerland Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.12.5.2 Pharmaceutical & biotechnology companies
- 16.12.5.2.1 Switzerland Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.12.5.3 Others
- 16.12.5.3.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 16.12.5.1 Hospitals & clinics
- 16.12.1 Switzerland Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.13 Belgium Radiotheranostics Market Size (2018-2030)
- 16.13.1 Belgium Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 16.13.1.1 Technetium-99
- 16.13.1.1.1 Belgium Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.2 Gallium-68
- 16.13.1.2.1 Belgium Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.3 Iodine-131
- 16.13.1.3.1 Belgium Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.4 Iodine-123
- 16.13.1.4.1 Belgium Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.5 18F
- 16.13.1.5.1 Belgium 18F Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.6 y-90
- 16.13.1.6.1 Belgium y-90 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.7 Lutetium (lu) 177
- 16.13.1.7.1 Belgium Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.8 Copper (Cu) 67
- 16.13.1.8.1 Belgium Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.9 Copper (Cu) 64
- 16.13.1.9.1 Belgium Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.10 Others
- 16.13.1.10.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.1 Technetium-99
- 16.13.2 Belgium Radiotheranostics Market (USD Million) by Application (2018-2030)
- 16.13.2.1 Oncology
- 16.13.2.1.1 Belgium Oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.13.2.2 Non-oncology
- 16.13.2.2.1 Belgium Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 16.13.2.1 Oncology
- 16.13.3 Belgium Radiotheranostics Market (USD Million) by Source (2018-2030)
- 16.13.3.1 Nuclear Reactors
- 16.13.3.1.1 Belgium Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.2 Cyclotrons
- 16.13.3.2.1 Belgium Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.1 Nuclear Reactors
- 16.13.4 Belgium Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 16.13.4.1 Targeted Therapeutic (Rx)
- 16.13.4.1.1 Belgium Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 16.13.4.2 Companion Diagnostic (DX)
- 16.13.4.2.1 Belgium Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 16.13.4.1 Targeted Therapeutic (Rx)
- 16.13.5 Belgium Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 16.13.5.1 Hospitals & clinics
- 16.13.5.1.1 Belgium Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.13.5.2 Pharmaceutical & biotechnology companies
- 16.13.5.2.1 Belgium Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 16.13.5.3 Others
- 16.13.5.3.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 16.13.5.1 Hospitals & clinics
- 16.13.1 Belgium Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.1 Asia Pacific
- 17.1.1 Asia Pacific Radiotheranostics Market Trends and Analysis
- 17.1.2 Asia Pacific Radiotheranostics Market by Country, 2018-2030
- 17.1.3 Asia Pacific Radiotheranostics Market Attractiveness Analysis by Country
- 17.2 Asia Pacific Radiotheranostics Market Size (2018-2030)
- 17.2.1 Asia Pacific Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.2.1.1 Technetium-99
- 17.2.1.1.1 Asia Pacific Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Gallium-68
- 17.2.1.2.1 Asia Pacific Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Iodine-131
- 17.2.1.3.1 Asia Pacific Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Iodine-123
- 17.2.1.4.1 Asia Pacific Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.5 18F
- 17.2.1.5.1 Asia Pacific 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.6 y-90
- 17.2.1.6.1 Asia Pacific y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.7 Lutetium (lu) 177
- 17.2.1.7.1 Asia Pacific Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.8 Copper (Cu) 67
- 17.2.1.8.1 Asia Pacific Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.9 Copper (Cu) 64
- 17.2.1.9.1 Asia Pacific Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.10 Others
- 17.2.1.10.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Technetium-99
- 17.2.2 Asia Pacific Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.2.2.1 Oncology
- 17.2.2.1.1 Asia Pacific Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Non-oncology
- 17.2.2.2.1 Asia Pacific Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Oncology
- 17.2.3 Asia Pacific Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.2.3.1 Nuclear Reactors
- 17.2.3.1.1 Asia Pacific Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Cyclotrons
- 17.2.3.2.1 Asia Pacific Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 Nuclear Reactors
- 17.2.4 Asia Pacific Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.2.4.1 Targeted Therapeutic (Rx)
- 17.2.4.1.1 Asia Pacific Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.2 Companion Diagnostic (DX)
- 17.2.4.2.1 Asia Pacific Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.1 Targeted Therapeutic (Rx)
- 17.2.5 Asia Pacific Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.2.5.1 Hospitals & clinics
- 17.2.5.1.1 Asia Pacific Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.2 Pharmaceutical & biotechnology companies
- 17.2.5.2.1 Asia Pacific Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.3 Others
- 17.2.5.3.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.1 Hospitals & clinics
- 17.2.1 Asia Pacific Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.3 China Radiotheranostics Market Size (2018-2030)
- 17.3.1 China Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.3.1.1 Technetium-99
- 17.3.1.1.1 China Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.2 Gallium-68
- 17.3.1.2.1 China Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.3 Iodine-131
- 17.3.1.3.1 China Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.4 Iodine-123
- 17.3.1.4.1 China Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.5 18F
- 17.3.1.5.1 China 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.6 y-90
- 17.3.1.6.1 China y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.7 Lutetium (lu) 177
- 17.3.1.7.1 China Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.8 Copper (Cu) 67
- 17.3.1.8.1 China Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.9 Copper (Cu) 64
- 17.3.1.9.1 China Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.10 Others
- 17.3.1.10.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.1 Technetium-99
- 17.3.2 China Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.3.2.1 Oncology
- 17.3.2.1.1 China Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.2 Non-oncology
- 17.3.2.2.1 China Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.1 Oncology
- 17.3.3 China Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.3.3.1 Nuclear Reactors
- 17.3.3.1.1 China Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.2 Cyclotrons
- 17.3.3.2.1 China Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.1 Nuclear Reactors
- 17.3.4 China Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.3.4.1 Targeted Therapeutic (Rx)
- 17.3.4.1.1 China Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.2 Companion Diagnostic (DX)
- 17.3.4.2.1 China Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.1 Targeted Therapeutic (Rx)
- 17.3.5 China Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.3.5.1 Hospitals & clinics
- 17.3.5.1.1 China Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.2 Pharmaceutical & biotechnology companies
- 17.3.5.2.1 China Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.3 Others
- 17.3.5.3.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.1 Hospitals & clinics
- 17.3.1 China Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.4 Japan Radiotheranostics Market Size (2018-2030)
- 17.4.1 Japan Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.4.1.1 Technetium-99
- 17.4.1.1.1 Japan Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.2 Gallium-68
- 17.4.1.2.1 Japan Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.3 Iodine-131
- 17.4.1.3.1 Japan Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.4 Iodine-123
- 17.4.1.4.1 Japan Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.5 18F
- 17.4.1.5.1 Japan 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.6 y-90
- 17.4.1.6.1 Japan y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.7 Lutetium (lu) 177
- 17.4.1.7.1 Japan Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.8 Copper (Cu) 67
- 17.4.1.8.1 Japan Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.9 Copper (Cu) 64
- 17.4.1.9.1 Japan Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.10 Others
- 17.4.1.10.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.1 Technetium-99
- 17.4.2 Japan Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.4.2.1 Oncology
- 17.4.2.1.1 Japan Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.2 Non-oncology
- 17.4.2.2.1 Japan Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.1 Oncology
- 17.4.3 Japan Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.4.3.1 Nuclear Reactors
- 17.4.3.1.1 Japan Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.2 Cyclotrons
- 17.4.3.2.1 Japan Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.1 Nuclear Reactors
- 17.4.4 Japan Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.4.4.1 Targeted Therapeutic (Rx)
- 17.4.4.1.1 Japan Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.2 Companion Diagnostic (DX)
- 17.4.4.2.1 Japan Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.1 Targeted Therapeutic (Rx)
- 17.4.5 Japan Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.4.5.1 Hospitals & clinics
- 17.4.5.1.1 Japan Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.2 Pharmaceutical & biotechnology companies
- 17.4.5.2.1 Japan Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.3 Others
- 17.4.5.3.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.1 Hospitals & clinics
- 17.4.1 Japan Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.5 Korea Radiotheranostics Market Size (2018-2030)
- 17.5.1 Korea Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.5.1.1 Technetium-99
- 17.5.1.1.1 Korea Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.2 Gallium-68
- 17.5.1.2.1 Korea Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.3 Iodine-131
- 17.5.1.3.1 Korea Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.4 Iodine-123
- 17.5.1.4.1 Korea Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.5 18F
- 17.5.1.5.1 Korea 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.6 y-90
- 17.5.1.6.1 Korea y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.7 Lutetium (lu) 177
- 17.5.1.7.1 Korea Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.8 Copper (Cu) 67
- 17.5.1.8.1 Korea Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.9 Copper (Cu) 64
- 17.5.1.9.1 Korea Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.10 Others
- 17.5.1.10.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.1 Technetium-99
- 17.5.2 Korea Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.5.2.1 Oncology
- 17.5.2.1.1 Korea Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.2 Non-oncology
- 17.5.2.2.1 Korea Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.1 Oncology
- 17.5.3 Korea Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.5.3.1 Nuclear Reactors
- 17.5.3.1.1 Korea Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.2 Cyclotrons
- 17.5.3.2.1 Korea Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.1 Nuclear Reactors
- 17.5.4 Korea Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.5.4.1 Targeted Therapeutic (Rx)
- 17.5.4.1.1 Korea Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.2 Companion Diagnostic (DX)
- 17.5.4.2.1 Korea Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.1 Targeted Therapeutic (Rx)
- 17.5.5 Korea Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.5.5.1 Hospitals & clinics
- 17.5.5.1.1 Korea Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.2 Pharmaceutical & biotechnology companies
- 17.5.5.2.1 Korea Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.3 Others
- 17.5.5.3.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.1 Hospitals & clinics
- 17.5.1 Korea Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.6 India Radiotheranostics Market Size (2018-2030)
- 17.6.1 India Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.6.1.1 Technetium-99
- 17.6.1.1.1 India Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.2 Gallium-68
- 17.6.1.2.1 India Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.3 Iodine-131
- 17.6.1.3.1 India Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.4 Iodine-123
- 17.6.1.4.1 India Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.5 18F
- 17.6.1.5.1 India 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.6 y-90
- 17.6.1.6.1 India y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.7 Lutetium (lu) 177
- 17.6.1.7.1 India Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.8 Copper (Cu) 67
- 17.6.1.8.1 India Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.9 Copper (Cu) 64
- 17.6.1.9.1 India Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.10 Others
- 17.6.1.10.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.1 Technetium-99
- 17.6.2 India Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.6.2.1 Oncology
- 17.6.2.1.1 India Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.2 Non-oncology
- 17.6.2.2.1 India Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.1 Oncology
- 17.6.3 India Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.6.3.1 Nuclear Reactors
- 17.6.3.1.1 India Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.2 Cyclotrons
- 17.6.3.2.1 India Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.1 Nuclear Reactors
- 17.6.4 India Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.6.4.1 Targeted Therapeutic (Rx)
- 17.6.4.1.1 India Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.2 Companion Diagnostic (DX)
- 17.6.4.2.1 India Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.1 Targeted Therapeutic (Rx)
- 17.6.5 India Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.6.5.1 Hospitals & clinics
- 17.6.5.1.1 India Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.2 Pharmaceutical & biotechnology companies
- 17.6.5.2.1 India Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.3 Others
- 17.6.5.3.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.1 Hospitals & clinics
- 17.6.1 India Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.7 Australia Radiotheranostics Market Size (2018-2030)
- 17.7.1 Australia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.7.1.1 Technetium-99
- 17.7.1.1.1 Australia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.2 Gallium-68
- 17.7.1.2.1 Australia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.3 Iodine-131
- 17.7.1.3.1 Australia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.4 Iodine-123
- 17.7.1.4.1 Australia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.5 18F
- 17.7.1.5.1 Australia 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.6 y-90
- 17.7.1.6.1 Australia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.7 Lutetium (lu) 177
- 17.7.1.7.1 Australia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.8 Copper (Cu) 67
- 17.7.1.8.1 Australia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.9 Copper (Cu) 64
- 17.7.1.9.1 Australia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.10 Others
- 17.7.1.10.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.1 Technetium-99
- 17.7.2 Australia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.7.2.1 Oncology
- 17.7.2.1.1 Australia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.2 Non-oncology
- 17.7.2.2.1 Australia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.1 Oncology
- 17.7.3 Australia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.7.3.1 Nuclear Reactors
- 17.7.3.1.1 Australia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.2 Cyclotrons
- 17.7.3.2.1 Australia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.1 Nuclear Reactors
- 17.7.4 Australia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.7.4.1 Targeted Therapeutic (Rx)
- 17.7.4.1.1 Australia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.2 Companion Diagnostic (DX)
- 17.7.4.2.1 Australia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.1 Targeted Therapeutic (Rx)
- 17.7.5 Australia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.7.5.1 Hospitals & clinics
- 17.7.5.1.1 Australia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.2 Pharmaceutical & biotechnology companies
- 17.7.5.2.1 Australia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.3 Others
- 17.7.5.3.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.1 Hospitals & clinics
- 17.7.1 Australia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.8 Philippines Radiotheranostics Market Size (2018-2030)
- 17.8.1 Philippines Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.8.1.1 Technetium-99
- 17.8.1.1.1 Philippines Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.2 Gallium-68
- 17.8.1.2.1 Philippines Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.3 Iodine-131
- 17.8.1.3.1 Philippines Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.4 Iodine-123
- 17.8.1.4.1 Philippines Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.5 18F
- 17.8.1.5.1 Philippines 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.6 y-90
- 17.8.1.6.1 Philippines y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.7 Lutetium (lu) 177
- 17.8.1.7.1 Philippines Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.8 Copper (Cu) 67
- 17.8.1.8.1 Philippines Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.9 Copper (Cu) 64
- 17.8.1.9.1 Philippines Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.10 Others
- 17.8.1.10.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.1 Technetium-99
- 17.8.2 Philippines Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.8.2.1 Oncology
- 17.8.2.1.1 Philippines Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.2 Non-oncology
- 17.8.2.2.1 Philippines Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.1 Oncology
- 17.8.3 Philippines Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.8.3.1 Nuclear Reactors
- 17.8.3.1.1 Philippines Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.2 Cyclotrons
- 17.8.3.2.1 Philippines Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.1 Nuclear Reactors
- 17.8.4 Philippines Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.8.4.1 Targeted Therapeutic (Rx)
- 17.8.4.1.1 Philippines Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.2 Companion Diagnostic (DX)
- 17.8.4.2.1 Philippines Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.1 Targeted Therapeutic (Rx)
- 17.8.5 Philippines Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.8.5.1 Hospitals & clinics
- 17.8.5.1.1 Philippines Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.2 Pharmaceutical & biotechnology companies
- 17.8.5.2.1 Philippines Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.3 Others
- 17.8.5.3.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.1 Hospitals & clinics
- 17.8.1 Philippines Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.9 Singapore Radiotheranostics Market Size (2018-2030)
- 17.9.1 Singapore Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.9.1.1 Technetium-99
- 17.9.1.1.1 Singapore Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.2 Gallium-68
- 17.9.1.2.1 Singapore Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.3 Iodine-131
- 17.9.1.3.1 Singapore Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.4 Iodine-123
- 17.9.1.4.1 Singapore Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.5 18F
- 17.9.1.5.1 Singapore 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.6 y-90
- 17.9.1.6.1 Singapore y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.7 Lutetium (lu) 177
- 17.9.1.7.1 Singapore Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.8 Copper (Cu) 67
- 17.9.1.8.1 Singapore Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.9 Copper (Cu) 64
- 17.9.1.9.1 Singapore Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.10 Others
- 17.9.1.10.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.1 Technetium-99
- 17.9.2 Singapore Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.9.2.1 Oncology
- 17.9.2.1.1 Singapore Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.2 Non-oncology
- 17.9.2.2.1 Singapore Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.1 Oncology
- 17.9.3 Singapore Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.9.3.1 Nuclear Reactors
- 17.9.3.1.1 Singapore Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.2 Cyclotrons
- 17.9.3.2.1 Singapore Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.1 Nuclear Reactors
- 17.9.4 Singapore Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.9.4.1 Targeted Therapeutic (Rx)
- 17.9.4.1.1 Singapore Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.9.4.2 Companion Diagnostic (DX)
- 17.9.4.2.1 Singapore Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.9.4.1 Targeted Therapeutic (Rx)
- 17.9.5 Singapore Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.9.5.1 Hospitals & clinics
- 17.9.5.1.1 Singapore Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.2 Pharmaceutical & biotechnology companies
- 17.9.5.2.1 Singapore Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.3 Others
- 17.9.5.3.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.1 Hospitals & clinics
- 17.9.1 Singapore Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.10 Malaysia Radiotheranostics Market Size (2018-2030)
- 17.10.1 Malaysia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.10.1.1 Technetium-99
- 17.10.1.1.1 Malaysia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.2 Gallium-68
- 17.10.1.2.1 Malaysia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.3 Iodine-131
- 17.10.1.3.1 Malaysia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.4 Iodine-123
- 17.10.1.4.1 Malaysia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.5 18F
- 17.10.1.5.1 Malaysia 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.6 y-90
- 17.10.1.6.1 Malaysia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.7 Lutetium (lu) 177
- 17.10.1.7.1 Malaysia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.8 Copper (Cu) 67
- 17.10.1.8.1 Malaysia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.9 Copper (Cu) 64
- 17.10.1.9.1 Malaysia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.10 Others
- 17.10.1.10.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.1 Technetium-99
- 17.10.2 Malaysia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.10.2.1 Oncology
- 17.10.2.1.1 Malaysia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.2 Non-oncology
- 17.10.2.2.1 Malaysia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.1 Oncology
- 17.10.3 Malaysia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.10.3.1 Nuclear Reactors
- 17.10.3.1.1 Malaysia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.2 Cyclotrons
- 17.10.3.2.1 Malaysia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.1 Nuclear Reactors
- 17.10.4 Malaysia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.10.4.1 Targeted Therapeutic (Rx)
- 17.10.4.1.1 Malaysia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.10.4.2 Companion Diagnostic (DX)
- 17.10.4.2.1 Malaysia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.10.4.1 Targeted Therapeutic (Rx)
- 17.10.5 Malaysia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.10.5.1 Hospitals & clinics
- 17.10.5.1.1 Malaysia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.2 Pharmaceutical & biotechnology companies
- 17.10.5.2.1 Malaysia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.3 Others
- 17.10.5.3.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.1 Hospitals & clinics
- 17.10.1 Malaysia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.11 Thailand Radiotheranostics Market Size (2018-2030)
- 17.11.1 Thailand Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.11.1.1 Technetium-99
- 17.11.1.1.1 Thailand Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.2 Gallium-68
- 17.11.1.2.1 Thailand Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.3 Iodine-131
- 17.11.1.3.1 Thailand Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.4 Iodine-123
- 17.11.1.4.1 Thailand Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.5 18F
- 17.11.1.5.1 Thailand 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.6 y-90
- 17.11.1.6.1 Thailand y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.7 Lutetium (lu) 177
- 17.11.1.7.1 Thailand Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.8 Copper (Cu) 67
- 17.11.1.8.1 Thailand Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.9 Copper (Cu) 64
- 17.11.1.9.1 Thailand Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.10 Others
- 17.11.1.10.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.1 Technetium-99
- 17.11.2 Thailand Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.11.2.1 Oncology
- 17.11.2.1.1 Thailand Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.2 Non-oncology
- 17.11.2.2.1 Thailand Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.1 Oncology
- 17.11.3 Thailand Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.11.3.1 Nuclear Reactors
- 17.11.3.1.1 Thailand Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.2 Cyclotrons
- 17.11.3.2.1 Thailand Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.1 Nuclear Reactors
- 17.11.4 Thailand Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.11.4.1 Targeted Therapeutic (Rx)
- 17.11.4.1.1 Thailand Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.11.4.2 Companion Diagnostic (DX)
- 17.11.4.2.1 Thailand Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.11.4.1 Targeted Therapeutic (Rx)
- 17.11.5 Thailand Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.11.5.1 Hospitals & clinics
- 17.11.5.1.1 Thailand Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.2 Pharmaceutical & biotechnology companies
- 17.11.5.2.1 Thailand Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.3 Others
- 17.11.5.3.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.1 Hospitals & clinics
- 17.11.1 Thailand Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.12 Indonesia Radiotheranostics Market Size (2018-2030)
- 17.12.1 Indonesia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.12.1.1 Technetium-99
- 17.12.1.1.1 Indonesia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.2 Gallium-68
- 17.12.1.2.1 Indonesia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.3 Iodine-131
- 17.12.1.3.1 Indonesia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.4 Iodine-123
- 17.12.1.4.1 Indonesia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.5 18F
- 17.12.1.5.1 Indonesia 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.6 y-90
- 17.12.1.6.1 Indonesia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.7 Lutetium (lu) 177
- 17.12.1.7.1 Indonesia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.8 Copper (Cu) 67
- 17.12.1.8.1 Indonesia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.9 Copper (Cu) 64
- 17.12.1.9.1 Indonesia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.10 Others
- 17.12.1.10.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.1 Technetium-99
- 17.12.2 Indonesia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.12.2.1 Oncology
- 17.12.2.1.1 Indonesia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.2 Non-oncology
- 17.12.2.2.1 Indonesia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.1 Oncology
- 17.12.3 Indonesia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.12.3.1 Nuclear Reactors
- 17.12.3.1.1 Indonesia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.2 Cyclotrons
- 17.12.3.2.1 Indonesia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.1 Nuclear Reactors
- 17.12.4 Indonesia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.12.4.1 Targeted Therapeutic (Rx)
- 17.12.4.1.1 Indonesia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.12.4.2 Companion Diagnostic (DX)
- 17.12.4.2.1 Indonesia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.12.4.1 Targeted Therapeutic (Rx)
- 17.12.5 Indonesia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.12.5.1 Hospitals & clinics
- 17.12.5.1.1 Indonesia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.2 Pharmaceutical & biotechnology companies
- 17.12.5.2.1 Indonesia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.3 Others
- 17.12.5.3.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.1 Hospitals & clinics
- 17.12.1 Indonesia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.13 Rest of APAC Radiotheranostics Market Size (2018-2030)
- 17.13.1 Rest of APAC Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 17.13.1.1 Technetium-99
- 17.13.1.1.1 Rest of APAC Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.2 Gallium-68
- 17.13.1.2.1 Rest of APAC Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.3 Iodine-131
- 17.13.1.3.1 Rest of APAC Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.4 Iodine-123
- 17.13.1.4.1 Rest of APAC Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.5 18F
- 17.13.1.5.1 Rest of APAC 18F Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.6 y-90
- 17.13.1.6.1 Rest of APAC y-90 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.7 Lutetium (lu) 177
- 17.13.1.7.1 Rest of APAC Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.8 Copper (Cu) 67
- 17.13.1.8.1 Rest of APAC Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.9 Copper (Cu) 64
- 17.13.1.9.1 Rest of APAC Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.10 Others
- 17.13.1.10.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.1 Technetium-99
- 17.13.2 Rest of APAC Radiotheranostics Market (USD Million) by Application (2018-2030)
- 17.13.2.1 Oncology
- 17.13.2.1.1 Rest of APAC Oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.2 Non-oncology
- 17.13.2.2.1 Rest of APAC Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.1 Oncology
- 17.13.3 Rest of APAC Radiotheranostics Market (USD Million) by Source (2018-2030)
- 17.13.3.1 Nuclear Reactors
- 17.13.3.1.1 Rest of APAC Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.2 Cyclotrons
- 17.13.3.2.1 Rest of APAC Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.1 Nuclear Reactors
- 17.13.4 Rest of APAC Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 17.13.4.1 Targeted Therapeutic (Rx)
- 17.13.4.1.1 Rest of APAC Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 17.13.4.2 Companion Diagnostic (DX)
- 17.13.4.2.1 Rest of APAC Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 17.13.4.1 Targeted Therapeutic (Rx)
- 17.13.5 Rest of APAC Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 17.13.5.1 Hospitals & clinics
- 17.13.5.1.1 Rest of APAC Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.2 Pharmaceutical & biotechnology companies
- 17.13.5.2.1 Rest of APAC Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.3 Others
- 17.13.5.3.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.1 Hospitals & clinics
- 17.13.1 Rest of APAC Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.1 Latin America
- 18.1.1 Latin America Radiotheranostics Market Trends and Analysis
- 18.1.2 Latin America Radiotheranostics Market by Country, 2018-2030
- 18.1.3 Latin America Radiotheranostics Market Attractiveness Analysis by Country
- 18.2 Latin America Radiotheranostics Market Size (2018-2030)
- 18.2.1 Latin America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.2.1.1 Technetium-99
- 18.2.1.1.1 Latin America Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.2 Gallium-68
- 18.2.1.2.1 Latin America Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.3 Iodine-131
- 18.2.1.3.1 Latin America Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.4 Iodine-123
- 18.2.1.4.1 Latin America Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.5 18F
- 18.2.1.5.1 Latin America 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.6 y-90
- 18.2.1.6.1 Latin America y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.7 Lutetium (lu) 177
- 18.2.1.7.1 Latin America Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.8 Copper (Cu) 67
- 18.2.1.8.1 Latin America Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.9 Copper (Cu) 64
- 18.2.1.9.1 Latin America Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.10 Others
- 18.2.1.10.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.1 Technetium-99
- 18.2.2 Latin America Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.2.2.1 Oncology
- 18.2.2.1.1 Latin America Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.2 Non-oncology
- 18.2.2.2.1 Latin America Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.1 Oncology
- 18.2.3 Latin America Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.2.3.1 Nuclear Reactors
- 18.2.3.1.1 Latin America Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.2 Cyclotrons
- 18.2.3.2.1 Latin America Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.1 Nuclear Reactors
- 18.2.4 Latin America Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.2.4.1 Targeted Therapeutic (Rx)
- 18.2.4.1.1 Latin America Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.2 Companion Diagnostic (DX)
- 18.2.4.2.1 Latin America Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.1 Targeted Therapeutic (Rx)
- 18.2.5 Latin America Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.2.5.1 Hospitals & clinics
- 18.2.5.1.1 Latin America Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.2 Pharmaceutical & biotechnology companies
- 18.2.5.2.1 Latin America Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.3 Others
- 18.2.5.3.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.1 Hospitals & clinics
- 18.2.1 Latin America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.3 Brazil Radiotheranostics Market Size (2018-2030)
- 18.3.1 Brazil Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.3.1.1 Technetium-99
- 18.3.1.1.1 Brazil Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.2 Gallium-68
- 18.3.1.2.1 Brazil Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.3 Iodine-131
- 18.3.1.3.1 Brazil Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.4 Iodine-123
- 18.3.1.4.1 Brazil Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.5 18F
- 18.3.1.5.1 Brazil 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.6 y-90
- 18.3.1.6.1 Brazil y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.7 Lutetium (lu) 177
- 18.3.1.7.1 Brazil Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.8 Copper (Cu) 67
- 18.3.1.8.1 Brazil Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.9 Copper (Cu) 64
- 18.3.1.9.1 Brazil Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.10 Others
- 18.3.1.10.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.1 Technetium-99
- 18.3.2 Brazil Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.3.2.1 Oncology
- 18.3.2.1.1 Brazil Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.2 Non-oncology
- 18.3.2.2.1 Brazil Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.1 Oncology
- 18.3.3 Brazil Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.3.3.1 Nuclear Reactors
- 18.3.3.1.1 Brazil Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.2 Cyclotrons
- 18.3.3.2.1 Brazil Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.1 Nuclear Reactors
- 18.3.4 Brazil Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.3.4.1 Targeted Therapeutic (Rx)
- 18.3.4.1.1 Brazil Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.2 Companion Diagnostic (DX)
- 18.3.4.2.1 Brazil Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.1 Targeted Therapeutic (Rx)
- 18.3.5 Brazil Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.3.5.1 Hospitals & clinics
- 18.3.5.1.1 Brazil Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.2 Pharmaceutical & biotechnology companies
- 18.3.5.2.1 Brazil Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.3 Others
- 18.3.5.3.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.1 Hospitals & clinics
- 18.3.1 Brazil Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.4 Argentina Radiotheranostics Market Size (2018-2030)
- 18.4.1 Argentina Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.4.1.1 Technetium-99
- 18.4.1.1.1 Argentina Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.2 Gallium-68
- 18.4.1.2.1 Argentina Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.3 Iodine-131
- 18.4.1.3.1 Argentina Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.4 Iodine-123
- 18.4.1.4.1 Argentina Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.5 18F
- 18.4.1.5.1 Argentina 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.6 y-90
- 18.4.1.6.1 Argentina y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.7 Lutetium (lu) 177
- 18.4.1.7.1 Argentina Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.8 Copper (Cu) 67
- 18.4.1.8.1 Argentina Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.9 Copper (Cu) 64
- 18.4.1.9.1 Argentina Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.10 Others
- 18.4.1.10.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.1 Technetium-99
- 18.4.2 Argentina Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.4.2.1 Oncology
- 18.4.2.1.1 Argentina Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.2 Non-oncology
- 18.4.2.2.1 Argentina Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.1 Oncology
- 18.4.3 Argentina Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.4.3.1 Nuclear Reactors
- 18.4.3.1.1 Argentina Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.2 Cyclotrons
- 18.4.3.2.1 Argentina Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.1 Nuclear Reactors
- 18.4.4 Argentina Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.4.4.1 Targeted Therapeutic (Rx)
- 18.4.4.1.1 Argentina Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.2 Companion Diagnostic (DX)
- 18.4.4.2.1 Argentina Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.1 Targeted Therapeutic (Rx)
- 18.4.5 Argentina Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.4.5.1 Hospitals & clinics
- 18.4.5.1.1 Argentina Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.2 Pharmaceutical & biotechnology companies
- 18.4.5.2.1 Argentina Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.3 Others
- 18.4.5.3.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.1 Hospitals & clinics
- 18.4.1 Argentina Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.5 Colombia Radiotheranostics Market Size (2018-2030)
- 18.5.1 Colombia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.5.1.1 Technetium-99
- 18.5.1.1.1 Colombia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.2 Gallium-68
- 18.5.1.2.1 Colombia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.3 Iodine-131
- 18.5.1.3.1 Colombia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.4 Iodine-123
- 18.5.1.4.1 Colombia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.5 18F
- 18.5.1.5.1 Colombia 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.6 y-90
- 18.5.1.6.1 Colombia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.7 Lutetium (lu) 177
- 18.5.1.7.1 Colombia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.8 Copper (Cu) 67
- 18.5.1.8.1 Colombia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.9 Copper (Cu) 64
- 18.5.1.9.1 Colombia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.10 Others
- 18.5.1.10.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.1 Technetium-99
- 18.5.2 Colombia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.5.2.1 Oncology
- 18.5.2.1.1 Colombia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.2 Non-oncology
- 18.5.2.2.1 Colombia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.1 Oncology
- 18.5.3 Colombia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.5.3.1 Nuclear Reactors
- 18.5.3.1.1 Colombia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.2 Cyclotrons
- 18.5.3.2.1 Colombia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.1 Nuclear Reactors
- 18.5.4 Colombia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.5.4.1 Targeted Therapeutic (Rx)
- 18.5.4.1.1 Colombia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.2 Companion Diagnostic (DX)
- 18.5.4.2.1 Colombia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.1 Targeted Therapeutic (Rx)
- 18.5.5 Colombia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.5.5.1 Hospitals & clinics
- 18.5.5.1.1 Colombia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.2 Pharmaceutical & biotechnology companies
- 18.5.5.2.1 Colombia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.3 Others
- 18.5.5.3.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.1 Hospitals & clinics
- 18.5.1 Colombia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.6 Peru Radiotheranostics Market Size (2018-2030)
- 18.6.1 Peru Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.6.1.1 Technetium-99
- 18.6.1.1.1 Peru Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.2 Gallium-68
- 18.6.1.2.1 Peru Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.3 Iodine-131
- 18.6.1.3.1 Peru Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.4 Iodine-123
- 18.6.1.4.1 Peru Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.5 18F
- 18.6.1.5.1 Peru 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.6 y-90
- 18.6.1.6.1 Peru y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.7 Lutetium (lu) 177
- 18.6.1.7.1 Peru Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.8 Copper (Cu) 67
- 18.6.1.8.1 Peru Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.9 Copper (Cu) 64
- 18.6.1.9.1 Peru Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.10 Others
- 18.6.1.10.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.1 Technetium-99
- 18.6.2 Peru Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.6.2.1 Oncology
- 18.6.2.1.1 Peru Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.2 Non-oncology
- 18.6.2.2.1 Peru Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.1 Oncology
- 18.6.3 Peru Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.6.3.1 Nuclear Reactors
- 18.6.3.1.1 Peru Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.2 Cyclotrons
- 18.6.3.2.1 Peru Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.1 Nuclear Reactors
- 18.6.4 Peru Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.6.4.1 Targeted Therapeutic (Rx)
- 18.6.4.1.1 Peru Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.2 Companion Diagnostic (DX)
- 18.6.4.2.1 Peru Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.1 Targeted Therapeutic (Rx)
- 18.6.5 Peru Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.6.5.1 Hospitals & clinics
- 18.6.5.1.1 Peru Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.2 Pharmaceutical & biotechnology companies
- 18.6.5.2.1 Peru Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.3 Others
- 18.6.5.3.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.1 Hospitals & clinics
- 18.6.1 Peru Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.7 Chile Radiotheranostics Market Size (2018-2030)
- 18.7.1 Chile Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.7.1.1 Technetium-99
- 18.7.1.1.1 Chile Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.2 Gallium-68
- 18.7.1.2.1 Chile Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.3 Iodine-131
- 18.7.1.3.1 Chile Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.4 Iodine-123
- 18.7.1.4.1 Chile Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.5 18F
- 18.7.1.5.1 Chile 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.6 y-90
- 18.7.1.6.1 Chile y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.7 Lutetium (lu) 177
- 18.7.1.7.1 Chile Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.8 Copper (Cu) 67
- 18.7.1.8.1 Chile Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.9 Copper (Cu) 64
- 18.7.1.9.1 Chile Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.10 Others
- 18.7.1.10.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.1 Technetium-99
- 18.7.2 Chile Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.7.2.1 Oncology
- 18.7.2.1.1 Chile Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.2 Non-oncology
- 18.7.2.2.1 Chile Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.1 Oncology
- 18.7.3 Chile Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.7.3.1 Nuclear Reactors
- 18.7.3.1.1 Chile Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.2 Cyclotrons
- 18.7.3.2.1 Chile Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.1 Nuclear Reactors
- 18.7.4 Chile Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.7.4.1 Targeted Therapeutic (Rx)
- 18.7.4.1.1 Chile Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.2 Companion Diagnostic (DX)
- 18.7.4.2.1 Chile Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.1 Targeted Therapeutic (Rx)
- 18.7.5 Chile Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.7.5.1 Hospitals & clinics
- 18.7.5.1.1 Chile Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.2 Pharmaceutical & biotechnology companies
- 18.7.5.2.1 Chile Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.3 Others
- 18.7.5.3.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.1 Hospitals & clinics
- 18.7.1 Chile Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.8 Rest of South America Radiotheranostics Market Size (2018-2030)
- 18.8.1 Rest of South America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 18.8.1.1 Technetium-99
- 18.8.1.1.1 Rest of South America Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.2 Gallium-68
- 18.8.1.2.1 Rest of South America Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.3 Iodine-131
- 18.8.1.3.1 Rest of South America Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.4 Iodine-123
- 18.8.1.4.1 Rest of South America Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.5 18F
- 18.8.1.5.1 Rest of South America 18F Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.6 y-90
- 18.8.1.6.1 Rest of South America y-90 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.7 Lutetium (lu) 177
- 18.8.1.7.1 Rest of South America Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.8 Copper (Cu) 67
- 18.8.1.8.1 Rest of South America Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.9 Copper (Cu) 64
- 18.8.1.9.1 Rest of South America Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.10 Others
- 18.8.1.10.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.1 Technetium-99
- 18.8.2 Rest of South America Radiotheranostics Market (USD Million) by Application (2018-2030)
- 18.8.2.1 Oncology
- 18.8.2.1.1 Rest of South America Oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.2 Non-oncology
- 18.8.2.2.1 Rest of South America Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.1 Oncology
- 18.8.3 Rest of South America Radiotheranostics Market (USD Million) by Source (2018-2030)
- 18.8.3.1 Nuclear Reactors
- 18.8.3.1.1 Rest of South America Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.2 Cyclotrons
- 18.8.3.2.1 Rest of South America Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.1 Nuclear Reactors
- 18.8.4 Rest of South America Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 18.8.4.1 Targeted Therapeutic (Rx)
- 18.8.4.1.1 Rest of South America Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.2 Companion Diagnostic (DX)
- 18.8.4.2.1 Rest of South America Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.1 Targeted Therapeutic (Rx)
- 18.8.5 Rest of South America Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 18.8.5.1 Hospitals & clinics
- 18.8.5.1.1 Rest of South America Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.2 Pharmaceutical & biotechnology companies
- 18.8.5.2.1 Rest of South America Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.3 Others
- 18.8.5.3.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.1 Hospitals & clinics
- 18.8.1 Rest of South America Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.1 Middle East and Africa
- 19.1.1 Middle East and Africa Radiotheranostics Market Trends and Analysis
- 19.1.2 Middle East and Africa Radiotheranostics Market by Country, 2018-2030
- 19.1.3 Middle East and Africa Radiotheranostics Market Attractiveness Analysis by Country
- 19.2 Middle East and Africa Radiotheranostics Market Size (2018-2030)
- 19.2.1 Middle East and Africa Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.2.1.1 Technetium-99
- 19.2.1.1.1 Middle East and Africa Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.2 Gallium-68
- 19.2.1.2.1 Middle East and Africa Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.3 Iodine-131
- 19.2.1.3.1 Middle East and Africa Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.4 Iodine-123
- 19.2.1.4.1 Middle East and Africa Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.5 18F
- 19.2.1.5.1 Middle East and Africa 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.6 y-90
- 19.2.1.6.1 Middle East and Africa y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.7 Lutetium (lu) 177
- 19.2.1.7.1 Middle East and Africa Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.8 Copper (Cu) 67
- 19.2.1.8.1 Middle East and Africa Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.9 Copper (Cu) 64
- 19.2.1.9.1 Middle East and Africa Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.10 Others
- 19.2.1.10.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.1 Technetium-99
- 19.2.2 Middle East and Africa Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.2.2.1 Oncology
- 19.2.2.1.1 Middle East and Africa Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.2 Non-oncology
- 19.2.2.2.1 Middle East and Africa Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.1 Oncology
- 19.2.3 Middle East and Africa Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.2.3.1 Nuclear Reactors
- 19.2.3.1.1 Middle East and Africa Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.2 Cyclotrons
- 19.2.3.2.1 Middle East and Africa Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.1 Nuclear Reactors
- 19.2.4 Middle East and Africa Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.2.4.1 Targeted Therapeutic (Rx)
- 19.2.4.1.1 Middle East and Africa Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.2.4.2 Companion Diagnostic (DX)
- 19.2.4.2.1 Middle East and Africa Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.2.4.1 Targeted Therapeutic (Rx)
- 19.2.5 Middle East and Africa Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.2.5.1 Hospitals & clinics
- 19.2.5.1.1 Middle East and Africa Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.2 Pharmaceutical & biotechnology companies
- 19.2.5.2.1 Middle East and Africa Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.3 Others
- 19.2.5.3.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.1 Hospitals & clinics
- 19.2.1 Middle East and Africa Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.3 Saudi Arabia Radiotheranostics Market Size (2018-2030)
- 19.3.1 Saudi Arabia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.3.1.1 Technetium-99
- 19.3.1.1.1 Saudi Arabia Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.2 Gallium-68
- 19.3.1.2.1 Saudi Arabia Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.3 Iodine-131
- 19.3.1.3.1 Saudi Arabia Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.4 Iodine-123
- 19.3.1.4.1 Saudi Arabia Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.5 18F
- 19.3.1.5.1 Saudi Arabia 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.6 y-90
- 19.3.1.6.1 Saudi Arabia y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.7 Lutetium (lu) 177
- 19.3.1.7.1 Saudi Arabia Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.8 Copper (Cu) 67
- 19.3.1.8.1 Saudi Arabia Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.9 Copper (Cu) 64
- 19.3.1.9.1 Saudi Arabia Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.10 Others
- 19.3.1.10.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.1 Technetium-99
- 19.3.2 Saudi Arabia Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.3.2.1 Oncology
- 19.3.2.1.1 Saudi Arabia Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.2 Non-oncology
- 19.3.2.2.1 Saudi Arabia Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.1 Oncology
- 19.3.3 Saudi Arabia Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.3.3.1 Nuclear Reactors
- 19.3.3.1.1 Saudi Arabia Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.2 Cyclotrons
- 19.3.3.2.1 Saudi Arabia Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.1 Nuclear Reactors
- 19.3.4 Saudi Arabia Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.3.4.1 Targeted Therapeutic (Rx)
- 19.3.4.1.1 Saudi Arabia Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.3.4.2 Companion Diagnostic (DX)
- 19.3.4.2.1 Saudi Arabia Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.3.4.1 Targeted Therapeutic (Rx)
- 19.3.5 Saudi Arabia Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.3.5.1 Hospitals & clinics
- 19.3.5.1.1 Saudi Arabia Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.2 Pharmaceutical & biotechnology companies
- 19.3.5.2.1 Saudi Arabia Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.3 Others
- 19.3.5.3.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.1 Hospitals & clinics
- 19.3.1 Saudi Arabia Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.4 Turkey Radiotheranostics Market Size (2018-2030)
- 19.4.1 Turkey Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.4.1.1 Technetium-99
- 19.4.1.1.1 Turkey Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.2 Gallium-68
- 19.4.1.2.1 Turkey Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.3 Iodine-131
- 19.4.1.3.1 Turkey Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.4 Iodine-123
- 19.4.1.4.1 Turkey Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.5 18F
- 19.4.1.5.1 Turkey 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.6 y-90
- 19.4.1.6.1 Turkey y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.7 Lutetium (lu) 177
- 19.4.1.7.1 Turkey Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.8 Copper (Cu) 67
- 19.4.1.8.1 Turkey Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.9 Copper (Cu) 64
- 19.4.1.9.1 Turkey Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.10 Others
- 19.4.1.10.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.1 Technetium-99
- 19.4.2 Turkey Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.4.2.1 Oncology
- 19.4.2.1.1 Turkey Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.2 Non-oncology
- 19.4.2.2.1 Turkey Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.1 Oncology
- 19.4.3 Turkey Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.4.3.1 Nuclear Reactors
- 19.4.3.1.1 Turkey Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.2 Cyclotrons
- 19.4.3.2.1 Turkey Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.1 Nuclear Reactors
- 19.4.4 Turkey Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.4.4.1 Targeted Therapeutic (Rx)
- 19.4.4.1.1 Turkey Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.4.4.2 Companion Diagnostic (DX)
- 19.4.4.2.1 Turkey Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.4.4.1 Targeted Therapeutic (Rx)
- 19.4.5 Turkey Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.4.5.1 Hospitals & clinics
- 19.4.5.1.1 Turkey Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.2 Pharmaceutical & biotechnology companies
- 19.4.5.2.1 Turkey Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.3 Others
- 19.4.5.3.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.1 Hospitals & clinics
- 19.4.1 Turkey Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.5 Nigeria Radiotheranostics Market Size (2018-2030)
- 19.5.1 Nigeria Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.5.1.1 Technetium-99
- 19.5.1.1.1 Nigeria Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.2 Gallium-68
- 19.5.1.2.1 Nigeria Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.3 Iodine-131
- 19.5.1.3.1 Nigeria Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.4 Iodine-123
- 19.5.1.4.1 Nigeria Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.5 18F
- 19.5.1.5.1 Nigeria 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.6 y-90
- 19.5.1.6.1 Nigeria y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.7 Lutetium (lu) 177
- 19.5.1.7.1 Nigeria Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.8 Copper (Cu) 67
- 19.5.1.8.1 Nigeria Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.9 Copper (Cu) 64
- 19.5.1.9.1 Nigeria Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.10 Others
- 19.5.1.10.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.1 Technetium-99
- 19.5.2 Nigeria Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.5.2.1 Oncology
- 19.5.2.1.1 Nigeria Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.2 Non-oncology
- 19.5.2.2.1 Nigeria Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.1 Oncology
- 19.5.3 Nigeria Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.5.3.1 Nuclear Reactors
- 19.5.3.1.1 Nigeria Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.2 Cyclotrons
- 19.5.3.2.1 Nigeria Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.1 Nuclear Reactors
- 19.5.4 Nigeria Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.5.4.1 Targeted Therapeutic (Rx)
- 19.5.4.1.1 Nigeria Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.5.4.2 Companion Diagnostic (DX)
- 19.5.4.2.1 Nigeria Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.5.4.1 Targeted Therapeutic (Rx)
- 19.5.5 Nigeria Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.5.5.1 Hospitals & clinics
- 19.5.5.1.1 Nigeria Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.2 Pharmaceutical & biotechnology companies
- 19.5.5.2.1 Nigeria Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.3 Others
- 19.5.5.3.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.1 Hospitals & clinics
- 19.5.1 Nigeria Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.6 UAE Radiotheranostics Market Size (2018-2030)
- 19.6.1 UAE Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.6.1.1 Technetium-99
- 19.6.1.1.1 UAE Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.2 Gallium-68
- 19.6.1.2.1 UAE Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.3 Iodine-131
- 19.6.1.3.1 UAE Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.4 Iodine-123
- 19.6.1.4.1 UAE Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.5 18F
- 19.6.1.5.1 UAE 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.6 y-90
- 19.6.1.6.1 UAE y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.7 Lutetium (lu) 177
- 19.6.1.7.1 UAE Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.8 Copper (Cu) 67
- 19.6.1.8.1 UAE Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.9 Copper (Cu) 64
- 19.6.1.9.1 UAE Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.10 Others
- 19.6.1.10.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.1 Technetium-99
- 19.6.2 UAE Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.6.2.1 Oncology
- 19.6.2.1.1 UAE Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.2 Non-oncology
- 19.6.2.2.1 UAE Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.1 Oncology
- 19.6.3 UAE Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.6.3.1 Nuclear Reactors
- 19.6.3.1.1 UAE Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.2 Cyclotrons
- 19.6.3.2.1 UAE Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.1 Nuclear Reactors
- 19.6.4 UAE Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.6.4.1 Targeted Therapeutic (Rx)
- 19.6.4.1.1 UAE Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.6.4.2 Companion Diagnostic (DX)
- 19.6.4.2.1 UAE Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.6.4.1 Targeted Therapeutic (Rx)
- 19.6.5 UAE Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.6.5.1 Hospitals & clinics
- 19.6.5.1.1 UAE Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.2 Pharmaceutical & biotechnology companies
- 19.6.5.2.1 UAE Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.3 Others
- 19.6.5.3.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.1 Hospitals & clinics
- 19.6.1 UAE Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.7 Egypt Radiotheranostics Market Size (2018-2030)
- 19.7.1 Egypt Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.7.1.1 Technetium-99
- 19.7.1.1.1 Egypt Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.2 Gallium-68
- 19.7.1.2.1 Egypt Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.3 Iodine-131
- 19.7.1.3.1 Egypt Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.4 Iodine-123
- 19.7.1.4.1 Egypt Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.5 18F
- 19.7.1.5.1 Egypt 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.6 y-90
- 19.7.1.6.1 Egypt y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.7 Lutetium (lu) 177
- 19.7.1.7.1 Egypt Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.8 Copper (Cu) 67
- 19.7.1.8.1 Egypt Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.9 Copper (Cu) 64
- 19.7.1.9.1 Egypt Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.10 Others
- 19.7.1.10.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.1 Technetium-99
- 19.7.2 Egypt Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.7.2.1 Oncology
- 19.7.2.1.1 Egypt Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.2 Non-oncology
- 19.7.2.2.1 Egypt Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.1 Oncology
- 19.7.3 Egypt Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.7.3.1 Nuclear Reactors
- 19.7.3.1.1 Egypt Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.2 Cyclotrons
- 19.7.3.2.1 Egypt Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.1 Nuclear Reactors
- 19.7.4 Egypt Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.7.4.1 Targeted Therapeutic (Rx)
- 19.7.4.1.1 Egypt Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.7.4.2 Companion Diagnostic (DX)
- 19.7.4.2.1 Egypt Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.7.4.1 Targeted Therapeutic (Rx)
- 19.7.5 Egypt Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.7.5.1 Hospitals & clinics
- 19.7.5.1.1 Egypt Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.2 Pharmaceutical & biotechnology companies
- 19.7.5.2.1 Egypt Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.3 Others
- 19.7.5.3.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.1 Hospitals & clinics
- 19.7.1 Egypt Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.8 South Africa Radiotheranostics Market Size (2018-2030)
- 19.8.1 South Africa Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.8.1.1 Technetium-99
- 19.8.1.1.1 South Africa Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.2 Gallium-68
- 19.8.1.2.1 South Africa Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.3 Iodine-131
- 19.8.1.3.1 South Africa Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.4 Iodine-123
- 19.8.1.4.1 South Africa Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.5 18F
- 19.8.1.5.1 South Africa 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.6 y-90
- 19.8.1.6.1 South Africa y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.7 Lutetium (lu) 177
- 19.8.1.7.1 South Africa Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.8 Copper (Cu) 67
- 19.8.1.8.1 South Africa Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.9 Copper (Cu) 64
- 19.8.1.9.1 South Africa Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.10 Others
- 19.8.1.10.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.1 Technetium-99
- 19.8.2 South Africa Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.8.2.1 Oncology
- 19.8.2.1.1 South Africa Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.2 Non-oncology
- 19.8.2.2.1 South Africa Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.1 Oncology
- 19.8.3 South Africa Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.8.3.1 Nuclear Reactors
- 19.8.3.1.1 South Africa Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.2 Cyclotrons
- 19.8.3.2.1 South Africa Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.1 Nuclear Reactors
- 19.8.4 South Africa Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.8.4.1 Targeted Therapeutic (Rx)
- 19.8.4.1.1 South Africa Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.8.4.2 Companion Diagnostic (DX)
- 19.8.4.2.1 South Africa Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.8.4.1 Targeted Therapeutic (Rx)
- 19.8.5 South Africa Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.8.5.1 Hospitals & clinics
- 19.8.5.1.1 South Africa Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.2 Pharmaceutical & biotechnology companies
- 19.8.5.2.1 South Africa Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.3 Others
- 19.8.5.3.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.1 Hospitals & clinics
- 19.8.1 South Africa Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.9 GCC Countries Radiotheranostics Market Size (2018-2030)
- 19.9.1 GCC Countries Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.9.1.1 Technetium-99
- 19.9.1.1.1 GCC Countries Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.2 Gallium-68
- 19.9.1.2.1 GCC Countries Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.3 Iodine-131
- 19.9.1.3.1 GCC Countries Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.4 Iodine-123
- 19.9.1.4.1 GCC Countries Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.5 18F
- 19.9.1.5.1 GCC Countries 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.6 y-90
- 19.9.1.6.1 GCC Countries y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.7 Lutetium (lu) 177
- 19.9.1.7.1 GCC Countries Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.8 Copper (Cu) 67
- 19.9.1.8.1 GCC Countries Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.9 Copper (Cu) 64
- 19.9.1.9.1 GCC Countries Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.10 Others
- 19.9.1.10.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 19.9.1.1 Technetium-99
- 19.9.2 GCC Countries Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.9.2.1 Oncology
- 19.9.2.1.1 GCC Countries Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.9.2.2 Non-oncology
- 19.9.2.2.1 GCC Countries Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.9.2.1 Oncology
- 19.9.3 GCC Countries Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.9.3.1 Nuclear Reactors
- 19.9.3.1.1 GCC Countries Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.9.3.2 Cyclotrons
- 19.9.3.2.1 GCC Countries Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.9.3.1 Nuclear Reactors
- 19.9.4 GCC Countries Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.9.4.1 Targeted Therapeutic (Rx)
- 19.9.4.1.1 GCC Countries Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.9.4.2 Companion Diagnostic (DX)
- 19.9.4.2.1 GCC Countries Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.9.4.1 Targeted Therapeutic (Rx)
- 19.9.5 GCC Countries Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.9.5.1 Hospitals & clinics
- 19.9.5.1.1 GCC Countries Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.9.5.2 Pharmaceutical & biotechnology companies
- 19.9.5.2.1 GCC Countries Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.9.5.3 Others
- 19.9.5.3.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 19.9.5.1 Hospitals & clinics
- 19.9.1 GCC Countries Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.10 Rest of MEA Radiotheranostics Market Size (2018-2030)
- 19.10.1 Rest of MEA Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 19.10.1.1 Technetium-99
- 19.10.1.1.1 Rest of MEA Technetium-99 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.2 Gallium-68
- 19.10.1.2.1 Rest of MEA Gallium-68 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.3 Iodine-131
- 19.10.1.3.1 Rest of MEA Iodine-131 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.4 Iodine-123
- 19.10.1.4.1 Rest of MEA Iodine-123 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.5 18F
- 19.10.1.5.1 Rest of MEA 18F Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.6 y-90
- 19.10.1.6.1 Rest of MEA y-90 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.7 Lutetium (lu) 177
- 19.10.1.7.1 Rest of MEA Lutetium (lu) 177 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.8 Copper (Cu) 67
- 19.10.1.8.1 Rest of MEA Copper (Cu) 67 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.9 Copper (Cu) 64
- 19.10.1.9.1 Rest of MEA Copper (Cu) 64 Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.10 Others
- 19.10.1.10.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 19.10.1.1 Technetium-99
- 19.10.2 Rest of MEA Radiotheranostics Market (USD Million) by Application (2018-2030)
- 19.10.2.1 Oncology
- 19.10.2.1.1 Rest of MEA Oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.10.2.2 Non-oncology
- 19.10.2.2.1 Rest of MEA Non-oncology Market Share and Revenue (USD Million) for 2018-2030
- 19.10.2.1 Oncology
- 19.10.3 Rest of MEA Radiotheranostics Market (USD Million) by Source (2018-2030)
- 19.10.3.1 Nuclear Reactors
- 19.10.3.1.1 Rest of MEA Nuclear Reactors Market Share and Revenue (USD Million) for 2018-2030
- 19.10.3.2 Cyclotrons
- 19.10.3.2.1 Rest of MEA Cyclotrons Market Share and Revenue (USD Million) for 2018-2030
- 19.10.3.1 Nuclear Reactors
- 19.10.4 Rest of MEA Radiotheranostics Market (USD Million) by Approach (2018-2030)
- 19.10.4.1 Targeted Therapeutic (Rx)
- 19.10.4.1.1 Rest of MEA Targeted Therapeutic (Rx) Market Share and Revenue (USD Million) for 2018-2030
- 19.10.4.2 Companion Diagnostic (DX)
- 19.10.4.2.1 Rest of MEA Companion Diagnostic (DX) Market Share and Revenue (USD Million) for 2018-2030
- 19.10.4.1 Targeted Therapeutic (Rx)
- 19.10.5 Rest of MEA Radiotheranostics Market (USD Million) by End-User (2018-2030)
- 19.10.5.1 Hospitals & clinics
- 19.10.5.1.1 Rest of MEA Hospitals & clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.10.5.2 Pharmaceutical & biotechnology companies
- 19.10.5.2.1 Rest of MEA Pharmaceutical & biotechnology companies Market Share and Revenue (USD Million) for 2018-2030
- 19.10.5.3 Others
- 19.10.5.3.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 19.10.5.1 Hospitals & clinics
- 19.10.1 Rest of MEA Radiotheranostics Market (USD Million) by Radioisotope (2018-2030)
- 20.1 Key Takeaways
- 20.2 Analyst Point of View
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Radiotheranostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Radiotheranostics Market Analysis
Global Radiotheranostics Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Radiotheranostics Industry growth. Radiotheranostics market has been segmented with the help of its Radioisotope, Application Source, and others. Radiotheranostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Radiotheranostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Radioisotope Analysed | |
Major Application Analysed | |
Major Source Analysed | Nuclear Reactors, Cyclotrons |
Major Approach Analysed | Targeted Therapeutic (Rx), Companion Diagnostic (DX) |
Major End-User Analysed | Hospitals & clinics, Pharmaceutical & biotechnology companies, Others |
Top Manufacturers Disclosed | |
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
Radioisotope Segment Analysis of Radiotheranostics Market
Based on present and future trends, the market size is estimated from 2018 to 2030. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Radiotheranostics market.
Radioisotope of Radiotheranostics analyzed in this report are as follows:
- Technetium-99
- Gallium-68
- Iodine-131
- Iodine-123
- 18F
- y-90
- Lutetium (lu) 177
- Copper (Cu) 67
- Copper (Cu) 64
- Others
Radiotheranostics Market Share (%) by Radioisotope in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Radiotheranostics Industry. Request a Free Sample PDF!
Application Segment Analysis of Radiotheranostics Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Radiotheranostics from 2018 to 2030. This will also help to analyze the demand for Radiotheranostics across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Application of Radiotheranostics are:
- Oncology
- Non-oncology
Radiotheranostics Market Share (%) by Application in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Radiotheranostics market report 2023 Edition by contacting our team.
Radiotheranostics Source Segment Analysis
- Nuclear Reactors
- Cyclotrons
Radiotheranostics Approach Segment Analysis
- Targeted Therapeutic (Rx)
- Companion Diagnostic (DX)
Radiotheranostics End-User Segment Analysis
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
- Others
Radiotheranostics Market Regional Analysis
Region and country analysis section of Radiotheranostics Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Radiotheranostics market.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Radiotheranostics Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Top Companies in Radiotheranostics Market
Competitive Landscape includes company profiling of the key manufacturers listed below. It also provides the key developments such as new product launches, expansion, mergers & acquisitions, partnerships, agreements, joint ventures, business overview, key strategies and financial analysis associated with the key players. Strategy implemented to overcome the COVID-19 Impact will be discussed in the report scope. Key players Financials includes Revenue (USD Million), Gross Margin (%) and Market Share (%) (2018- 2022), S.W.O.T Analysis, (To read more request the sample pages Or speak to analyst/author directly).
Top Companies Market Share in Radiotheranostics Industry: (In no particular order of Rank)
- Transcode Therapeutics Inc
- Curium Sas
- Ge Healthcare Inc
- Bayer Ag
- Lantheus Medical
- Imaging Inc
- Novartis Ag
- Spectrum Pharmaceuticals Inc
- Ipsen Sa
- Actinium Pharmaceuticals Inc (Atnm)
- Nordic Nanovector Asa
- Y-Mabs Therapeutics Inc
- Sofie Biosciences Inc
- Terumo Corporation
- Sirtex Medical Limited
- Boston Scientific Corporation
- Nihon Medi-Physics
- Itm Isotopen Technologien München Ag
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- Theragnostics Ltd
- Nuview Life Sciences
- Jubilant Pharma Limited
- Clarity Pharmaceuticals
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Radiotheranostics Market is witnessing significant growth in the near future.
In 2022, the Technetium-99 segment accounted for noticeable share of global Radiotheranostics Market and is projected to experience significant growth in the near future.
The Oncology segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Transcode Therapeutics Inc, Ge Healthcare Inc and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
Surabhi Bhaiyya, LinkedIn
Senior Research Analyst at Cognitive Market Research
Surabhi Bhaiyya is an experienced market researcher focused on the Pharma & Healthcare industry. With over 7+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry. To get in touch and access the above report book an apointment at https://calendly.com/speak-to-analyst.
Key Questions Answered By Radiotheranostics Market Report 2023
Why Technetium-99 have a significant impact on Radiotheranostics market? |
What are the key factors affecting the Technetium-99 and Gallium-68 of Radiotheranostics Market? |
What is the CAGR/Growth Rate of Oncology during the forecast period? |
By type, which segment accounted for largest share of the global Radiotheranostics Market? |
Which region is expected to dominate the global Radiotheranostics Market within the forecast period? |
Frequently Asked Questions
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Radiotheranostics market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Radiotheranostics market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more